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CHAPTER I 
Introduction 
Breast cancer overview 
Cancer remains a leading cause of death worldwide.  According to the 
latest reports from the World Health Organization (WHO) in 2008, cancer 
accounted for 7.6 million deaths worldwide.  About 70% of all cancer deaths 
occurred in low- and middle- income countries.  Deaths from cancer worldwide 
are projected to continue to rise to over 13 million in 2030 (Siegel et al., 2011). 
In the United States, the American Cancer Society (ACS) estimates 
approximately 1.7 million new cancer cases to be diagnosed in 2012.  Invasive 
breast cancers diagnosed in women will account for about 226,870 of these new 
cases (Siegel et al., 2011).  Breast cancer is still the most common cancer 
among American women, with the exception of skin cancers (Siegel et al., 2011). 
In fact breast cancer remains the second leading cause of cancer-related death 
in women.  The ACS estimates about 39,510 women will tragically lose their 
battle against breast cancer in 2012.  Women diagnosed with aggressive and/or 
more advanced forms of breast cancer have a meager 26% five-year survival 
rate.  While the battle against cancer continues, the ACS reports that earlier 
detection through screening and increased awareness, as well as advances in 
improved treatment options have significantly improved patient outcomes and 
survival.  Death rates from breast cancer have been declining since about 1990, 
with larger decreases in women younger than 50.  This decline is likely due to 
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increases in the prevalence of mammography screening and also decreased use 
of menopausal hormones following the publication of the Women’s Health 
Initiative randomized trial results (Ravdin et al., 2007 and Coombs et al., 2010). 
Currently, there are more than 2.6 million breast cancer survivors in the United 
States (Siegel et al., 2011).  Despite significant advances in diagnosing and 
treating breast cancer, several major unresolved clinical and scientific problems 
remain.  Hence, the search for more effective preventative strategies and 
improved treatments for cancer patients continue to drive those involved in 
cancer research.  
While the exact etiology of breast cancer is unknown, there are a number 
of important risk factors that have been identified.  The use of hormone therapy 
following menopause, obesity, and alcohol consumption have all been shown to 
increase risk in women (Coombs et al., 2010; La Vecchia et al., 2011; Pelucchi et 
al., 2011).  Other factors that increase risk include a long menstrual history, use 
of oral contraceptives, never having children, age at first full-term pregnancy, 
exposure to radiation and breast density (Madigan et al., 1995; McCormack and 
dos Santos, 2006).  Although most women with breast cancer do not have a 
family history of the disease, it is one of the strongest determinants of risk, 
suggesting hereditary factors such as germline mutations in breast cancer 
susceptibility gene 1 (BRCA1) and breast cancer susceptibility gene 2 (BRCA2) 
increase risk (Miki et al., 1994; Roy et al., 2011).  BRCA1 has been implicated in 
controlling the cell cycle by its ability to interact with various cyclins and cyclin-
dependent kinases (CDKs) (Yoshida and Miki, 2004).  Also, BRCA1 is known to 
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induce the activity/expression of the negative cell cycle regulators, CDK inhibitor 
p21 and the p53 tumor suppressor gene.  Both of these breast cancer 
susceptibility genes also play a key role during homologous recombination (HR), 
a vital process employed during repair of DNA double strand breaks and stalled 
DNA replication (Moynahan et al., 1999).  Therefore the loss of BRCA1 or 
BRCA2 may lead to impairment of HR providing an enhanced opportunity for a 
cell to become transformed.  Notably, inherited mutations in breast cancer 
susceptibility genes account for approximately 5%-10% of all female and male 
breast cancer cases (Brody and Biesecker, 1998; Ellisen and Haber, 1998).  
Like many other types of cancer, breast cancer is not a single disease but 
it is highly heterogeneous at both the molecular and clinical level.  The natural 
course of breast tumorigenesis involves a multistep process through defined 
pathological and clinical stages, starting with ductal hyperproliferation, with 
subsequent evolution into in situ and invasive carcinomas, and finally into 
metastatic disease (Sakorafas and Tsiotou, 2000).  These steps reflect genetic 
alterations that propel the progressive transformation of normal mammary 
epithelial cells (MEC) into highly malignant derivatives.  During tumorigenesis 
there are a variety of biological capabilities acquired by tumor cells, recognized 
as the hallmarks of cancer (Hanahan and Weinberg, 2000).  Included in these 
hallmarks of cancer is the ability of tumor cells to resist cell death.  Over several 
decades, it has become evident that cell death serves as a natural barrier to 
tumorigenesis. 
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Different types of programmed cell death 
Programmed cell death (PCD) plays a vital role during animal 
development and tissue homeostasis (Fuchs and Steller, 2011).  Abnormal 
regulation of this process is associated with a wide variety of human diseases, 
including neurodegeneration, immunological and developmental disorders, as 
well as cancer (Thompson, 1995; Fuchs and Steller, 2011).  Studies of normal 
and cancerous cells led to the definition of three main forms of cell death.  It is 
generally understood that apoptotic (type I) cell death requires two cells: the 
dying cell and the phagocyte that digests the dead cell with the help of the 
phagocyte lysosome (Savill and Fadok, 2000).  Autophagic (type II) cell death 
depends on the dying cells' own lysosomes and a self-cannibalization process 
known as autophagy (Klionsky and Emr, 2000).  Nonlysosomal (type III) cell 
death, also known as necrosis, is associated with membrane leakage and 
inflammation without any role for the lysosome (Proskuryakov et al., 2003).  It 
should also be noted that a single stimulus often triggers several distinct death 
programs concurrently.  Normally, only the fastest and most effective death 
pathway is evident, but one cell may also display characteristics of several death 
programs simultaneously (Hirsch et al., 1997; Zeiss, 2003; Elmore, 2007).  
 
Apoptosis 
Kerr and his colleagues coined the expression “apoptosis” when 
describing specific morphological features of dying cells.  Their ultrastructure 
studies revealed rounding-up of the dying cell (shrinking) while organelles and 
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plasma membrane retained their integrity (Kerr et al., 1972).  In addition, they 
proposed this process reflects the operation of an active, intracellular death 
program that can be activated or inhibited by a variety of physiological or 
pathological environmental stimuli.  It wasn’t until two decades later that our 
understanding of apoptosis progressed when Horvitz and colleagues performed 
screens to identify genes that are required for programmed cell death in the 
worm Caenorhabditis elegans (Horvitz, 1999).  These studies provided many 
important advances in our understanding of apoptosis.  
The apoptosis cascade can be initiated via two major pathways, involving 
either activation of death receptors in response to ligand binding (extrinsic or 
death receptor pathway) or the release of proapoptotic proteins, such as 
cytochrome c, from mitochondria to cytosol (intrinsic or mitochondrial pathway) 
(Elmore, 2007).  However, evidence now suggests that both pathways are linked 
and that molecules in one pathway can influence the other (Igney and Krammer, 
2002).  The central players in both pathways are the caspases (the cysteine 
dependent, aspartate specific family of proteases), which function as the main 
executors of apoptotic cell death (Cohen, 1997).  Regulated at the post-
translational level, caspases are synthesized and exist within the cell as inactive 
pro-caspases or zymogens.  Under stimulation of pro-apoptotic signals, pro-
caspases are cleaved by proteases to become active caspases (Yuan et al., 
1993; Miura et al., 1993; Cohen, 1997).  
Fragmentation of internucleosomal DNA (karyorrhexis) is a feature of 
apoptosis (Elmore, 2007).  Lamins are intra-nuclear proteins that maintain the 
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shape of the nucleus and mediate interactions between the nuclear membrane 
and chromatin.  Degradation of lamins by caspases results in chromatin 
condensation (pyknosis) and nuclear fragmentation (Elmore, 2007).  Retraction 
of pseudopods, blebbing of the plasma membrane along with formation of 
apoptotic bodies that contain nuclear or cytoplasmic material are also changes 
that occur before plasma membrane integrity is lost and the cell dies through 
apoptosis (Elmore, 2007).  
Various techniques are commonly used to detect these apoptotic features 
such as caspase activation assays, DNA laddering assays, as well as measuring 
cellular DNA content by flow cytometry (Muppidi et al., 2004).  When measuring 
cellular DNA content cells are permeabilized.  During this procedure fragmented 
DNA multimers leak out of the cell.  The result is a population of cells with 
reduced DNA content.  If the cells are then stained with a DNA intercalating dye 
(e.g., propidium iodide) then a DNA profile representing cells in G1, S-phase, and 
G2M will be observed with apoptotic cells being represented by a sub G0/G1 
population (Muppidi et al., 2004).  
In addition to these biochemical features, changes in several cell surface 
molecules are also observed.  The presence of cell surface molecules ensures 
that apoptotic cells are immediately recognized and phagocytized by neighboring 
cells in tissues, resulting in many cells being removed from tissues relatively 
quickly (Bratton et al., 1997).  The clearance of such dying cells is mediated 
either by phagocytes that are professional engulfers: macrophages and immature 
dendritic cells (Aderem and Underhill, 1999; Sauter et al., 2000; Fadok et al., 
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1992; 2001) or neighboring cells: fibroblasts and epithelial cells (Monks et al., 
2008). Elimination of dying cells through apoptosis prevents an inflammatory 
response (Savill and Fadok, 2000; Kurosaka et al., 2003). 
The multi-step process involved in the clearance of dying cells is a 
complex one. One of the first steps is the “find-me” signals (such as low levels of 
nucleotides adenosine triphosphate (ATP) and uridine triphosphate (UTP)) 
released by apoptotic cells (Lauber et al., 2004).  The find-me signal helps attract 
motile phagocytes to the proximity of the cell undergoing apoptosis (Lauber et al., 
2004).  Although find-me signals can guide phagocytes to the proximity of 
apoptotic cells within a tissue, the specific recognition of the dying cell among the 
neighboring live cells depends on eat-me signals exposed by the apoptotic cells 
(Lauber et al., 2004; Gardai et al., 2006). To date, multiple eat-me signals have 
been identified (Gardai et al., 2006). Among these is exposure of 
phosphatidylserine (PtdSer) on the outer leaflet of the plasma membrane.  This is 
the most universally seen alteration on the surface of apoptotic cells (Fadok et 
al., 1992, 2001).  In fact, PtdSer exposure is the best studied and the most 
accepted definition for calling a cell apoptotic.  
 
Autophagic cell death 
Apoptotic cell death continues to be the most studied and best 
characterized cell death mechanism at both genetic and biochemical levels. 
However, there is evidence that other PCD mechanisms exist.  Autophagic 
(Type-II) PCD occurs in the absence of chromatin condensation but is 
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accompanied by massive autophagic vacuolization of the cytoplasm (Gozuacik 
and Kimchi, 2004).  The existence of autophagic cell death continues to be a 
topic of debate and more recent evidence indicates that cell death is not 
executed by autophagy, but that autophagic cell death simply describes cell 
death with autophagy (Levine and Yuan, 2005).  
The catabolic process of autophagy is an evolutionarily conserved cellular 
process and responsible for self-cannibalization through a lysosomal degradation 
pathway (Levine and Klionsky, 2004).  It is a multi-step process that is 
characterized by the formation of double-membrane vesicles called 
autophagosomes.  These autophagosomes engulf bulk cytoplasm, which leads 
to the degradation of long-lived or damaged proteins and the turnover of various 
cytoplasmic organelles such as mitochondria, endoplasmic reticulum (ER), and 
Golgi (Levine and Klionsky, 2004; Meijer and Codogno, 2004).  Eventually, the 
outer membrane of autophagosomes fuse with lysosomes generating 
autolysosomes, where acidic lysosomal hydrolases degrade the cytoplasm-
derived contents of the autophagosome together with its inner membrane (Levine 
and Klionsky, 2004). This process takes place in cells at a basal level where it 
plays a pivotal role in housekeeping or disposal of assorted cytoplasmic 
components comprising of damaged organelles and of toxic, aggregation-prone 
proteins.  The individual components are then used as renewable resources to 
provide components and energy for cell survival (Meijer and Codogno, 2004; 
Wang and Klionsky, 2003).  In addition, autophagy is essential for maintaining 
cell survival following a variety of extracellular and intracellular stimuli including 
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ER stress, oxidative stress, nutrient-starvation, and growth factor deprivation 
(Levine and Klionsky, 2004). Amino acids, fatty acids, and nucleic acids 
generated by this process can be used for protein synthesis, or can be oxidized 
by the mitochondrial electron transport chain to produce ATP for cell survival 
under harsh conditions.  Yet, this mechanism of cell autonomous survival is 
inevitably self-limited and the ultimate consequence is autophagy-mediated cell 
death if the stress imposed on the cell is sustained (Gozuacik and Kimchi, 2004). 
Autophagy was first detected by electron microscopy (Klionsky, 2007). 
Degradation of cytoplasmic areas sequestered by the phagophore, which 
matures into the prelysosomal autophagosome remains the hallmark of 
autophagy (Klionsky, 2007).  The functional significance of this process was 
unknown until the 1990s when autophagy-related genes (ATG) in the yeast 
Saccharomyces cerevisiae were discovered in response to starvation.  These 
genes are highly conserved among eukaryotes (Nakatogawa et al., 2009).  To 
date, over 30 ATG genes have been identified in yeast and at least 11 (ATG1, 3, 
4, 5, 6, 7, 8, 9, 10, 12 and 16) have orthologs in mammals (Krick et al., 2011). 
ATG6 is also known as Beclin 1 (BECN1) and ATG8 is referred to as microtuble-
associated protein light chain 3 (LC3) in mammals (Klionsky, 2007).  
LC3 is the first mammalian protein known to specifically associate with 
autophagosomes (Kabeya et al., 2000).  LC3 is synthesized as proLC3, which is 
cleaved by Atg4B to form LC3-I, with the carboxyl terminal glycine exposed 
(Figure 1). LC3-I binds the elongating preautophagosomal membrane after 
activation by Atg7.  LC3-I is then transferred to Atg3, and finally conjugated to  
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Figure 1. Model of autophagosome formation.  Atg5-Atg12 conjugate and 
Atg16L localize to the isolation membrane (phagophore) during the elongation 
process.  ProLC3 is processed for recruitment to the membrane in an Atg5-
dependent manner.  Atg12-Atg5 and Atg16L dissociate from the membrane upon 
completion of autophagosome formation, while LC3-II remains on the 
autophagosome membrane.  Modified from Gozuacik and Kimchi, 2004 and 
Yoshimori and Noda, 2008.  
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phosphatidylethanolamine (PE) (Kabeya et al., 2000; Geng and Klionsky, 2008). 
The LC3-PE conjugate is referred to as LC3-II (Kabeya et al., 2000).  The 
proteolytic cleavage converts LC3 from an 18kD (LC3-I) to a 16kD (LC3-II) 
protein.  The conversion of soluble or cytosolic form of LC3 (LC3-I) to the 
autophagosome-associated form (LC3-II) is a well-accepted autophagosomal 
marker (Klionsky et al., 2007).  LC3-II on the cytoplasmic surface of 
autophagosomes is delipidated by Atg4B to recycle LC3-I for further 
autophagosome formation. 
To date, ultrastructural analysis of autophagosome formation using 
electron microscopy together with the detection of processed LC3 by western 
blot or fluorescence studies have been the conventional methods for autophagy 
detection (Klionsky et al., 2007).  Mitochondrial dilation, extensive intracellular 
membrane remodeling, and the generation of other autophagic acidic vesicles 
(AV) are also characteristics of autophagy.  There is a long list of guidelines for 
monitoring and interpreting the results of autophagy assays (Klionsky et al., 
2008).  As with any experimental methods, each has its strengths and limitations.   
 
Necrosis 
Necrotic (type III) cell death or necrosis is morphologically distinguishable 
by a gain in cell volume (oncosis), swelling of organelles, plasma membrane 
rupture and subsequent loss of intracellular contents (Elmore, 2007).  Necrosis is 
caused by factors external to the cell or tissue, such as infection, toxins, or 
trauma.  One major difference between type I-II cell death and type III necrotic  
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cell death is that necrosis can lead to local inflammation, presumably through the 
liberation of factors from dead cells that alert the innate immune system (Kanduc 
et al., 2002).  As necrotic cells swell, they are internalized by a macropinocytotic 
mechanism, with the implication that phagocytes take up only parts of the cell.  
As research in this area has progressed, sequences of biochemical events that 
define necrosis have been described.  Production of reactive oxygen species 
(ROS) by mitochondria and swelling of mitochondria, ATP depletion, failure of 
calcium homeostasis, perinuclear clustering of organelles, activation of a few 
non-caspase proteases, specifically cathepsins and calpains, lysosomal rupture, 
and ultimately plasma membrane rupture occur in necrotic cells (Golstein and 
Kroemer, 2007).   
While necrosis has been traditionally seen as a passive and uncontrolled 
form of cell death, proteins that finely regulate this process have been identified 
recently (Barros et al., 2001).  Necrosis is activated by death domain receptors 
[e.g. tumor necrosis factor receptor 1 (TNFR1), Fas/CD95, and TNF-related 
apoptosis-inducing ligand receptor (TRAIL-R)] and Toll-like receptors (e.g. TLR3 
and TLR4), in particular in the presence of caspase inhibitors (Festjens et al., 
2006).  This necrotic cell death seemingly depends on the serine/threonine 
kinase receptor-interacting protein kinase-1 (RIP-1); this has been demonstrated 
by its knockout/knockdown and chemical inhibition by a small molecule inhibitor 
necrostatin-1 (Nec-1) (Christofferson and Yuan, 2010).  This form of cell death is 
termed ‘‘necroptosis” (Christofferson and Yuan, 2010; Yuan and Kroemer, 2010).  
This area is relatively new and further studies are required to fully comprehend 
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the similarities and differences involved between necrosis and necroptosis. 
Besides the conventional three types of PCD, other pathways have been 
discovered.  These pathways are called "nonapoptotic programmed cell death" or 
"caspase-independent programmed cell death".  These alternative routes to 
death are as efficient as apoptosis and can occur concomitantly with apoptosis or 
function as an alternative cell death mechanism when apoptosis is impaired. 
Increasing evidence indicates that nonapoptotic cell death mechanisms mediate 
such important developmental processes as interdigital cell death and hollowing 
of the mammary ducts during puberty (Chautan et al., 1999; Debnath et al., 
2005; Degterev et al., 2005; Mailleux et al., 2007).  One specific mechanism of 
cell death that has recently received much attention is the cell internalization 
process termed entosis (Overholtzer et al., 2007). 
  
Entosis and Cell engulfment 
Entosis is described as a nonapoptotic cell death mechanism that occurs 
in matrix-detached cells, where viable target cells invade into viable host cells, 
forming cell-in-cell structures (Overholtzer et al., 2007).  While apoptosis can also 
result in the internalization of one cell inside of another, the mechanisms 
responsible for entosis are substantially distinct.  The fate of entotic cells varies. 
Internalized cells can be released; but the most common fate of internalized cells 
is cell death (Overholtzer et al., 2007).  Entotic cells are targeted to lysosomal 
compartments where they are degraded.  In trying to decipher a mechanism for 
entotic cell death, Florey et al. show a role for autophagy in entosis.  During 
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entosis, the entotic vacuole membrane encircling internalized cells recruits the 
autophagy protein LC3 (Florey et al., 2011).  This was shown to be independent 
of autophagosome formation, yet dependent on ATG5, ATG7, and VPS34, which 
are all part of autophagy machinery (Florey et al., 2011).  LC3-targeted entotic 
vacuoles recruit lysosomes, resulting in the degradation of internalized cells, 
which are killed by their hosts.  Autophagy protein inhibitors can significantly 
increase the level of transformed growth of cells undergoing high rates of entosis. 
These data suggest that entosis may suppress transformed growth by inducing 
cell death, using proteins important in the autophagy process (Florey et al., 
2011). 
Interestingly, entosis is not the first description of a process that leads to 
cell-in-cell structures.  Reports of cell-in-cell structures date back to the mid 
1800’s (Overholtzer and Brugge, 2008).  Many terms have been used in the 
literature to describe cell-in-cell structures including entosis, emperipolesis, 
cytophagocytosis, and cannibalism (xeno-cannibalism).  Humble et al. were the 
first to introduce the term emperipolesis in the 1950’s to refer to a heterogeneous 
cell-in-cell phenomenon in which viable lymphocytes move into malignant cells 
(Humble et al., 1956).  During cell cannibalism, the cannibalistic (host) cell comes 
in contact with the target cell.  The next step is the gradual engulfment of the cell 
cytoplasm of the target cell.  The nucleus of the target cell appears unaltered; yet 
the nucleus of the host cell is pressed to one side, changing into a crescent or 
semilunar shape (Humble et al., 1956; Sharma and Dey, 2011).  Finally the 
target cell completely dies off and its nucleus disintegrates.  There is some 
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evidence implying the lack of nutrients as the cause of death of target cells.  
It has been proposed that emperipolesis denotes the process of cells 
entering, moving within, as well as exiting the cell, whereas cytophagocytosis, 
cannibalism, and entosis describe the specific mechanism of cell-in-cell formation 
(Overholtzer and Brugge, 2008).  While there are some overlapping similarities 
among the various mechanisms, entosis is a mechanism whereby target cells 
invade the host cell (Overholtzer et al., 2007).  Conversely, in cell cannibalism a 
host cell actively engulfs the target cell.  The ability of cannibal tumor cells to 
engulf other tumor cells resembles autophagic digestion of cellular organelles. 
Cell cannibalism has been frequently detected in highly malignant or 
metastatic tumors and has been correlated with poor prognosis (Sharma and 
Dey, 2011).  This could possibly be due to the tumor cell’s ability to ingest 
immune cells such as lymphocytes and neutrophils for immune evasion 
(Overholtzer and Brugge, 2008; Sharma and Dey, 2011).  In contrast, natural 
killer (NK) cell internalization has been shown to precede target tumor cell death 
and NK cell self-destruction, suggesting that this cell-in-cell pathway is a 
mechanism to kill tumor cells (Xia et al., 2008).  This potential tumor suppressive 
function is similar to that observed in soft agar assays during entosis 
(Overholtzer et al., 2007).  Nevertheless, the significance of cell-in-cell structures 
and the underlying mechanism(s) of their formation remain unknown.  
Information on factors that stimulate or regulate cell engulfment is almost 
nonexistent.  One such protein that may play a role in stimulating engulfment of 
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cells is the transcription factor CCAAT/enhancer-binding protein beta 
(C/EBPbeta). 
CCAAT/enhancer-binding protein family 
C/EBPbeta is one of the members of the CCAAT/enhancer-binding protein 
family.  These DNA binding transcription factors belong to the basic leucine 
zipper superfamily of transcription factors (Tsukada et al., 2011).  The following 
six genes encode the C/EBP family including:  C/EBPalpha, C/EBPbeta, 
C/EBPgamma, C/EBPdelta, C/EBPepsilon, and C/EBPzeta (Lekstrom-Himes 
and Xanthopoulos, 1998; Ramji and Foka, 2002).  Members of this superfamily 
are characterized by a leucine zipper motif, which allows them to homodimerize 
or heterodimerize with other members of the family (Tsukada et al, 2011).  Upon 
dimerization, the C/EBPs exploit their basic domain to bind to the specific 
consensus sequence: TTnnG(C/T)AAT in the promoters of countless genes 
(Tsukada et al., 2011).  The carboxyl (C)-terminal region contains both the DNA 
binding in addition to the dimerization motifs.  It is this C-terminal region that is 
highly conserved within the family.  The members of the C/EBPs are divergent in 
their amino (N)-terminal region containing regulatory and transactivation domains 
that interact with transcriptional coactivators, corepressors, and the basal 
transcription machinery (Tsukada et al., 2011). Although these family members 
can bind the same target sequences in gene promoters, it is the interaction with 
the numerous binding partners that successfully determines specificity.  Overall, 
C/EBPs have been shown to play important roles in growth control and the 
induction of differentiation (Tsukada et al., 2011).  
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The C/EBPs are a fascinating and complex family of transcription factors. 
C/EBPgamma, C/EBPdelta, and C/EBPzeta exist as single polypeptides, 
whereas multiple polypeptides are generated through alternative splicing and 
regulated translation initiation from the genes encoding C/EBPalpha, C/EBPbeta, 
and C/EBPepsilon (Ramji and Foka, 2002).  C/EBPalpha is the founding member 
of the C/EBP family and was first identified as a liver-enriched DNA binding 
protein (Johnson and McKnight, 1989).  Genetic deletion studies of individual 
C/EBPs in mice revealed information regarding expression patterns as well as 
their ability to cooperate in essential roles in the development and function of 
various tissue types (Lekstrom-Himes and Xanthopoulos, 1998; Ramji and Foka, 
2002).  Some of the members (e.g. C/EBPPbeta, C/EBPgamma, and 
C/EBPzeta) are ubiquitously expressed; most of the C/EBPs are expressed and 
involved in tissue-specific gene expression in the liver, lung, intestine, bone, 
adipose tissue, immune cells, ovary and breast (Ramji and Foka, 2002).  
 
C/EBPbeta 
In the early 1990’s C/EBPbeta was independently identified by separate 
groups of investigators working on different model systems. Shiazu Akira and 
colleagues identified the factor then cloned the protein from a human 
glioblastoma cell line and referred to it as nuclear factor-interleukin 6 (NF-IL6). 
This was due to the fact that it is a nuclear factor and it can activate the 
interleukin-6 promoter (Akira et al., 1990).  In regards to the rat and mouse 
proteins, Patrick Descombes and Ueli Schibler identified the protein from rat liver 
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extracts and named the larger, activator isoforms liver-enriched activator protein 
(LAP) and the smaller, inhibitory isoform liver-enriched inhibitory protein (LIP) 
(Descombes et al., 1990). AGP/EBP, IL6-DBP, CRP2, and NF-M (chicken 
protein) are terms scarcely used in the literature since it was later realized that 
these proteins displayed homology to the recently identified CCAAT/enhancer 
binging protein (now referred to as C/EBPalpha) cloned in the laboratory of Steve 
McKnight (Landschulz et al., 1988; Ramji and Foka, 2002).  
C/EBPbeta is transcribed from an intronless gene that gives rise to three 
protein isoforms from a single messenger RNA (mRNA) (Figure 2).  This is due 
to alternative translation initiation at three in-frame methionine initiator codons or 
regulated proteolysis (Descombes et al., 1991; Ramji and Foka, 2002).  In 
humans, full-length C/EBPbeta1 is 346 amino acids long (Akira et al., 1990) (297 
in rat and mouse (Cao et al., 1991; Descombes et al., 1990) and has an apparent 
molecular weight of 55 kilodalton (kD).  C/EBPbeta2 begins at the second in-
frame methionine located 23 amino acid downstream from the first.  C/EBPbeta2 
appears as a doublet on immunoblots with an apparent molecular weight of 45kD 
and 42kD.  The smallest isoform, C/EBPbeta3, begins at the final in-frame 
methionine at position 198 in the human protein and has an apparent molecular 
weight of 20kD (Descombes and Schibler, 1991).  The structure of C/EBPbeta is 
such that the transactivation domain resides in the N-terminal region and the 
protein dimerization (leucine zipper) and DNA binding domains (basic region) 
reside in the C-terminal end.  Unlike the first two transcription activator isoforms,  
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Figure 2. Schematic representation of C/EBPbeta.  Three proteins isoforms 
are generated from a single mRNA by alternative translation.  The positions of 
the three ATG start codons and the relative sizes of each isoform are shown.  
The positions of epitopes recognized by two antibodies are also depicted.  
 
 
 
 
 
 
 
	   20	  
C/EBPbeta1 and C/EBPbeta2 (termed LAP* and LAP in rodents), the third 
isoform, C/EBPbeta3 (termed LIP in rodents) lacks the entire N-terminal 
activation domain, while retaining the DNA binding/protein dimerization domain 
(Descombes and Schibler, 1991).  Therefore, this protein acts as a transcriptional 
repressor since it can occupy the C/EBPbeta consensus DNA elements within 
promoters of target genes. 
 
Isoform specific C/EBPbeta expression 
Several mechanisms by which a cell regulates the production of a specific 
C/EBPbeta isoform have been proposed.  One of the earliest explanations is that 
the three isoforms arise by a “leaky” ribosome scanning mechanism (Descombes 
and Schibler, 1991).  Since then, there has been more complex mechanisms 
proposed; some that specifically lead to increases in C/EBPbeta3 (hereafter 
referred to as LIP) protein expression. 
Mammalian target of rapamycin (mTOR) and additional signal 
transduction pathways that regulate the function of the translation initiation 
factors such as eukaryotic translation initiation factor (eIF2) alpha and eIF-4E 
have been shown to determine the ratio of C/EBP isoforms (Raught et al., 1996) 
Calkhoven and colleagues showed that high eIF2alpha activity leads to 
increased LIP production.  Alternative translation initiation involves a highly 
conserved small upstream open reading frame (uORF) at the 5’ region of 
C/EBPbeta mRNA (Lincoln et al., 1998; Calkhoven et al., 2000; Wethmar et al., 
2010).  Studies of molecular mechanisms that control the initiation of translation 
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on the uORF-specific AUG codon suggested that certain RNA-binding proteins 
might regulate this process by interacting with the uORF region of C/EBPbeta 
mRNA.  Two RNA-binding proteins, CUG triplet repeat binding protein (CUGBP1) 
and calreticulin (CRT), which specifically bind to the uORF were identified to be 
important players in regulating LIP translation (Timchenko et al., 1999; 2002; 
2006).  Although CUGBP1 and CRT interact with the same sequence of the 5′ 
region of C/EBPbeta mRNA, the consequences of these interactions are 
different.  CRT binds to the 5′ region of C/EBPbeta mRNA and stabilizes a stem-
loop (SL) structure, leading to the inhibition of translation of C/EBPbeta.  On the 
contrary, the interaction of CUGBP1 with the 5′ region of C/EBPbeta mRNA 
increases translation of C/EBPbeta (Timchenko et al., 1999; 2002; 2006).  It is 
not surprising that cells have highly regulated mechanisms to control translation 
initiation of the C/EBPbeta isoforms, since each have been linked to specific 
biological processes.  
The second proposed mechanism to generate LIP is through specific 
proteolysis of the larger C/EBPbeta isoforms.  In vivo studies have shown 
specific cleavage of the larger isoforms results in an increase in LIP protein 
levels (Welm et al., 2000; Baer and Johnson, 2000).  This was shown to occur in 
the liver and depend on C/EBPalpha; it is likely that this occurs in other tissues 
as well (Welm et al., 2000).  It is of great importance to note that in vitro cleavage 
of the larger C/EBPbeta isoforms can also occur (Baer and Johnson, 2000).  LIP 
can be generated through artifactual proteolysis depending on the method used 
during sample preparation.  Hence, there are discrepancies in the literature 
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regarding the production of LIP in cells.  
Most of the research on C/EBPbeta has focused on the C/EBPbeta2 
(LAP) and C/EBPbeta3 (LIP) isoforms.  Until recently, many investigators failed 
to acknowledge the existence of C/EBPbeta1 (LAP*), due to its low expression 
levels in cultured cells.  Historically there was this notion that C/EBPbeta1 and 
C/EBPbeta2 were functionally redundant, since they only differ by a 23 N-
terminal amino acid truncation and both are transcriptional activators.  However, 
mounting evidence by our lab and others demonstrate that the three C/EBPbeta 
isoforms have very different and unique roles in cells.  C/EBPbeta1 plays 
important functions in differentiation and senescence (Kowenz-Leutz and Leutz, 
1999; Eaton, et al., 2001; Eaton and Sealy, 2003; Atwood and Sealy, 2010), 
while C/EBPbeta2 participates in more proliferative roles in cells (Bundy and 
Sealy, 2003).  This is evident in the ability of C/EBPbeta1, not C/EBPbeta2, to 
synergistically collaborate with c-Myb in co-expression assays to turn on 
differentiation genes in myeloid cells.  Unlike C/EBPbeta2, C/EBPbeta1 was able 
to activate differentiation genes by interacting with and recruiting the SWI/SNF 
chromatin-remodeling complex (Kowenz-Leutz and Leutz, 1999). This 
recruitment was dependent on the N-terminal amino acids present in 
C/EBPbeta1, but not C/EBPbeta2.  In addition, the N-terminal amino acids 
unique to C/EBPbeta1 are necessary for efficient sumoylation (SUMO) (Eaton 
and Sealy, 2003).  Briefly, sumoylation is a post-translational modification that 
has been shown to regulate the function of various proteins (Geiss-Friedlander 
and Melchior, 2007).  Specifically, sumoylation of transcription factors leads to 
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transcriptional repression by altering binding partners.  C/EBPbeta1 is the only 
transactivator isoform that is sumoylated in COS cells even though both 
C/EBPbeta1 and C/EBPbeta2 contain a SUMO consensus sequence around 
lysine 173 (Eaton and Sealy, 2003).  More recently, our lab found that 
C/EBPbeta1 more efficiently induces senescence than C/EBPbeta2 (Atwood and 
Sealy, 2010).  This is likely due to the ability of C/EBPbeta1 to induce interleukin-
6 (IL-6) expression (Atwood and Sealy, 2010).  Interestingly, expression of sumo-
C/EBPbeta1 fusion protein does not induce IL-6 in comparison to expression of 
wild-type C/EBPbeta1, indicating that sumoylation of C/EBPbeta1 does lead to 
transcriptional repression (Atwood and Sealy, 2011). 
Differences in protein expression have also been observed in mammary 
epithelial cells.  C/EBPbeta1 is found in normal mammary epithelial cells from 
reduction mammoplasties, whereas C/EBPbeta2 is undetectable (Eaton et al., 
2001).  Interestingly, in human breast tumors, where cancer cells are actively 
proliferating, there is a significant gain of C/EBPbeta2 protein levels (Eaton et al., 
2001).  In fact, C/EBPbeta 2 but not C/EBPbeta1, was observed to transactivate 
the promoters of cyclin D1 (Eaton et al., 2001) and placenta specific 1 (PLAC1) 
genes (Koslowski, et al., 2009), which promote proliferation and are frequently 
upregulated in breast tumors.  Moreover, overexpression of C/EBPbeta2 in the 
MCF10A mammary epithelial cell line leads to cell transformation (Bundy and 
Sealy, 2003).  C/EBPbeta2-expressing MCF10A cells form foci, gain 
anchorage independence, express markers associated with having 
undergone an epithelial-to-mesenchymal transition (EMT), and acquire an 
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invasive phenotype (Bundy and Sealy, 2003).  The role of LIP in cells 
continues to be a topic of debate and will be discussed further in greater detail in 
the next chapters.  
 
Role of C/EBPbeta in the mammary gland 
Genetic deletion of C/EBPbeta in mice revealed the importance of this 
transcription factor in a number of physiological processes.  The C/EBPbeta null 
mice exhibit a number of dramatic phenotypes including impaired liver 
regeneration, increased sensitivity to infections, sterility, and defects in mammary 
gland development (Greenbaum et al., 1998; Sterneck et al., 1997; Robinson et 
al., 1998; Seagroves et al., 1998).  The mammary gland is a dynamic organ, 
which undergoes growth and extraordinary remodeling in response to hormonal 
signals at puberty, pregnancy and continues through weaning of the offspring 
(Figure 3A).  During embryonic development, a rudimentary epithelial ductal tree 
is formed which remains mostly unchanged until puberty.  During puberty, 
estrogen stimulates the expansion and development of the ductal tree and 
lobuloalveolar structures at the ends of the ducts.  During gestation, estrogen 
and progesterone stimulate additional proliferation and further development of 
the ducts and lobuloalveoli.  Following parturition, epithelial cells differentiate into 
secretory epithelial cells for milk production and secretion.  After lactation, the 
mammary epithelial ductal tree regresses to a quiescent state through the 
process of involution (Sternlicht et al., 2006).  The involution process 
encompasses several changes including the reabsorption of residual milk, loss of 
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the epithelium by programmed cell death, clearance of these dying cells, and 
regrowth of the interstitial adipose cells.  This regressed state has mistakenly 
been thought to be the same as the gland in the nulliparous state, before the first 
pregnancy and lactation.  However, D’Cruz et al. have described a host of gene-
expression changes of the mammary gland following pregnancy and lactation, 
(D’Cruz et al., 2002) and distinct genetic signatures have been reported for the 
parous and nulliparous human breast (Balogh et al., 2006).  During the involution 
process, many secretory and epithelial cells undergo massive cell death; this has 
been shown to involve several forms of cell death including apoptosis, 
autophagy, and cell engulfment (Zarzynska and Motyl, 2008; Monks et al., 2008).  
This process of epithelial cell growth, differentiation, and involution of the 
mammary gland occurs with each pregnancy. 
In wild type mice extensive mammary gland development occurs around 
three weeks of age during puberty (Figure 3B).  This fascinating process of 
developing normal mammary glands is well orchestrated and arises from an 
epithelial cell bud proximal to the nipple.   At puberty, the epithelial cells divide 
and migrate to penetrate the mammary fat pad, forming the ductal tree.  
Secondary and tertiary branching ducts stem from the primary ducts.  These 
secondary and tertiary branching ducts also penetrate the fat pad. One way to 
measure the development of the mammary gland in mice is to monitor the 
position of the epithelial tree in relation to the distal lymph node in the inguinal 
mammary gland.   
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Figure 3. Mouse mammary gland development.  A, schematic 
representation of the stages of mammary gland development in the adult 
mouse, from pre-puberty to gestation, lactation and involution.  B, whole 
mount images of the different stages a, puberty; b, mature virgin; c, 
pregnancy; d, lactation; e, post-involution.  LN, lymph node; TEB, terminal 
end bud.  Modified from Watson and Khaled, 2008; Hennighausen and 
Robinson, 2005. 
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In 1998, studies were published describing the mammary gland 
deficiencies of two independently created C/EBPbeta knockout mice.  Studies by  
Jeff Rosen and colleagues as well as Peter Johnson and colleagues reveal that 
C/EBPbeta is essential for proliferation of lobuloalveolar secretory units and 
ductal morphogenesis (Robinson et al., 1998; Seagroves et al., 1998). 
C/EBPbeta null mice have obvious defects in epithelial cell penetration into the 
mammary fat pad.  In contrast to extensive lobuloalveolar development observed 
in C/EBPbeta heterozygous mammary glands, large areas of ductal epithelium 
of the C/EBPbeta null glands do not contain secondary/tertiary side branches or 
alveoli (Figure 4).  Ducts that do form appear enlarged and produce distended 
ends. Both beta-casein and whey acidic protein expression are inhibited or 
absent in C/EBPbeta null mice (Grimm and Rosen, 2003).  These data provide 
evidence for the essential role of C/EBPbeta in mammary epithelial proliferation 
in response to hormonal stimulation at puberty or gestation.  Furthermore, the 
studies depict the importance of C/EBPbeta in functional differentiation of 
secretory epithelium in the mammary gland.  Taken together, C/EBPbeta is a 
crucial component in both proliferation and differentiation in mammary epithelial 
cells.  The mechanism by which C/EBPbeta is directing these antagonistic 
processes is likely due to the distinct functional properties of the three 
C/EBPbeta isoforms. 
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Figure 4. Lobuloalveolar development is compromised in the C/EBPbeta 
null mice upon stimulation of pregnancy with estrogen and progesterone. 
Since C/EBPbeta null females are sterile, pregnancy in these studies was 
simulated by treatment with estrogen and progesterone.  Following treatment, 
thoracic mammary glands are isolated from C/EBPbeta+/- and C/EBPbeta-/- 
mice treated with estrogen and progesterone.  The glands were fixed and stained 
with hematoxylin for whole mount preparation.  In contrast to extensive 
lobuloalveolar development observed in A, the C/EBPbeta+/− glands, large 
areas of ductal epithelium in B, the C/EBPbeta−/− glands did not contain either 
secondary/tertiary side branches or alveoli.  Also, ducts that form appear 
enlarged as indicated by the red arrow. (Modified from Seagroves et al., 1998) 
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C/EBPbeta in Breast cancer 
 With the establishment that C/EBPbeta is an important player in  
proliferation during mammary gland development, many investigators focused 
their attention on the role of this protein in cancer.  Increased C/EBPbeta 
expression has been detected in ovarian tumors, colorectal tumors, and breast 
tumors (Sundfeldt et al., 1999; Rask et al., 2000; Staiger et al., 2009; Grimm and 
Rosen, 2003; Bundy and Sealy, 2003).  Increases in C/EBPbeta mRNA have 
been detected in 18 of 18 MMTV/c-neu mammary tumors, approximately 2-5 fold 
over levels expressed during lactation or involution (Dearth et al., 2001). 
However, this does not provide information on which isoform is being 
upregulated.  Some studies have described elevated levels of LIP in both murine 
mammary hyperplasia and in human breast cancers (Zahnow et al., 1997; 
Zahnow et al., 2001).  It has been argued that the transcriptional inhibitor LIP 
isoform is predominantly expressed during proliferative cellular responses and is 
associated with aggressive tumors (Zahnow et al., 1997).  It has also been 
reported that expression of LIP under the control of the whey acidic promoter 
(WAP) in the mouse mammary gland results in the formation of hyperplastic 
tissue, and more infrequently, carcinomas (Zahnow et al., 2001).  However, 
because the LIP transgene was not epitope-tagged in these mice it is not 
possible to ascertain transgene expression from any endogenous LIP 
expression.  Moreover, the level of LIP expression (transgene or endogenous) in 
the mammary tumors was not actually examined.  Zahnow et al. have stated that 
LIP is overexpressed in 23% of infiltrating ductal carcinomas specimens.  Yet,  
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Figure 5. C/EBPbeta isoform expression in mammary samples.  Whole cell 
extracts were prepared from A, normal breast tissue from reductive 
mammoplasty or B, breast tumors obtained from the Tissue Procurement Core at 
Vanderbilt University.  Immunoblot analysis was performed using either the C-
terminal or N-terminal C/EBPbeta antibody as indicated.  Modified from Eaton, et 
al., 2001. 
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our own study on primary breast tumor samples found that high grade, invasive 
mammary carcinomas showed significant C/EBPbeta2 expression, but no LIP 
protein was detected in any of the samples (Figure 5) (Eaton et al., 2001).  LIP is 
known to be easily generated by artifactual proteolysis of the larger isoforms, 
which could explain this discrepancy (Baer and Johnson, 2000). 
 We wanted to address this issue by overexpressing each C/EBPbeta 
isoform individually in a normal MEC line model.  Overexpression of C/EBPbeta2 
(but not C/EBPbeta1 or LIP) results in a variety of cancer phenotypes.  In 
previous studies by our lab, we asked whether LIP could confer epidermal growth 
factor (EGF)-independent growth of MCF10A cells (Bundy et al., 2005).  In 
contrast to C/EBPbeta2, a high level of LIP expression is incompatible with 
continued proliferation.  In fact, our data reveals a remarkable increase in cell 
death of LIP-expressing cells, even in the presence of EGF (Bundy et al., 2005). 
 
Purpose of this Study 
  In recent years, huge strides have been made in pursuing transcription 
factors as anticancer targets (Karamouzis et al., 2002; Frank, 2009). 
Therapeutics directed at C/EBPbeta are promising, not only for cancer, but for 
many other diseases.  C/EBPbeta is known to play key roles in diverse 
pathological conditions such as human immunodeficiency virus (HIV), diabetes, 
as well as various inflammatory diseases.  Nevertheless, it is essential to find 
ways to target a specific isoform, since the three are functionally distinct.  Recent 
findings in our laboratory corroborate the importance of C/EBPbeta, specifically 
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C/EBPbeta1, in oncogene-induced senescence (Atwood and Sealy, 2010).  Also, 
we found C/EBPbeta1 to be negatively regulated during transformation.  We 
previously demonstrated a role for C/EBPbeta2 in promoting tumor cell 
proliferation and transformation (Bundy and Sealy, 2003).  On the other hand, 
overexpression of C/EBPbeta1 or LIP does not promote tumor cell proliferation.  
Yet, the exact role of LIP in cancer is unclear.  The main objective of this work is 
to examine the role of LIP in breast cancer in order to gain a better 
understanding of whether LIP is a tumor-promoter, tumor-suppressor, or both.  
 These studies demonstrate high levels of LIP stimulate cell death in breast 
cancer cell lines.  Moreover, my work shows that LIP leads to a nonapoptotic cell 
death process in breast cancer cell lines involving cell engulfment and 
autophagy.  The central hypothesis to be tested is that as a transcriptional 
repressor, LIP stimulates cell death in breast cancer cells by altering the cellular 
transcriptional program.   
 
Significance 
 The apoptotic cell death pathway has been one of the major emphases in 
anticancer therapeutics.  However, a critical step in tumor formation and 
progression is the ability of tumor cells to evade apoptosis, resulting in malignant 
cells that will not die (Hanahan and Weinberg, 2000).  Apoptosis is complex 
mechanism and encompasses many pathways.  Errors can transpire at any point 
along these pathways, leading to not only malignant transformation of the 
affected cells, but many times to tumor cell metastasis and resistance to 
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anticancer therapies.  
 Several alternative cell death pathways have been recently described. The 
aims of this work focus on characterizing the induction of autophagy as well as 
describing the ability to engulf neighboring cells which ultimately leads to cell 
death upon LIP expression in breast cancer cell lines.  It is clear that knowledge 
of mechanisms and identification of new agents capable of inducing alternative 
cell death pathways has vast potential to improve cancer therapeutics.  
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CHAPTER II 
C/EBPbeta3 (LIP) and autophagy 
Introduction 
 Autophagy is a process involving the bulk degradation of cellular 
components in the cytoplasm via the lysosomal degradation pathway (Levine and 
Klionsky, 2004).  Autophagy manifests a protective role in stressful conditions 
such as nutrient or growth factor depletion; however, extensive degradation of 
regulatory molecules or organelles essential for survival can lead to the demise 
of the cell, or autophagy-mediated cell death (Gozuacik and Kimchi, 2004).  The 
role of autophagy in cancer is complex with roles in both tumor suppression and 
tumor promotion proposed (Hippert et al., 2006).  
Activation of autophagy may lead to different outcomes depending on the 
cell genetic background as well as the duration and strength of the stress-
inducing stimulus.  It has been suggested that in early stages of tumor formation, 
a defective autophagic system leads to the accumulation of damaged proteins 
and organelles.  This increase in genotoxic substances may lead to both failure 
to constrain cell growth and mutations.  Yet, at later stages of tumorigenesis, 
autophagy may be a means by which tumor cells survive under oxygen and 
nutrient limiting conditions, providing extra time for adaptation via the induction of 
angiogenesis and/or motility and invasion (Hippert et al., 2006).  The 
mechanisms by which autophagy may be regulated to provide complete cellular 
destruction or a survival advantage remain unknown. 
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One mechanism by which autophagy is regulated is through 
transcriptional control.  This area has become more intricate with recent studies 
focusing on the roles of different transcription factors and their ability to induce or 
regulate autophagy in a cell context and stimulus specific manner.  An example 
of this is the activation of E2 factor 1 (E2F1), which upregulates the expression of 
autophagy genes: LC3, autophagy related 1 (ATG1), and damage-regulated 
autophagy modulator (DRAM) by directly binding to their promoters (Polager et 
al., 2008).  Other findings indicate dual roles for the transcription factor p53 in 
autophagy.  Tasdemir et al. reports cytoplasmic p53 negatively regulates 
autophagosome formation (Tasdemir et al., 2008).  Others have shown that 
nuclear p53 directly induces DRAM and autophagy (Crighton et al., 2006). The 
transcription factor nuclear factor kappa B (NF-κB) controls the expression of 
Beclin 1 by interacting with the BECN1 promoter (Copetti et al., 2009).  Also, c-
Jun N-terminal kinase (JNK) has been shown to control the expression of Beclin 
1 through c-Jun.  JNK controls autophagy by both cytoplasmic and nuclear 
effects (Li et al., 2009).  Recent studies implicate forkhead box O (FoxO) 
transcription factors in promoting autophagy (Sengupta et al., 2009).  Taken 
together, we hypothesize that the C/EBPbeta isoform, LIP, is another member of 
the group of transcription factors, including E2F1, NF-kB, and p53, which are 
capable of playing a role in autophagy. 
 In this study, I show that LIP stimulates autophagy and induces cell death 
in human breast cancer cells.  Overexpression of LIP is incompatible with cell 
proliferation and when cell cycle analysis was performed, a DNA profile of cells 
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undergoing apoptosis was not observed.  Instead, LIP expressing cells appeared 
to have large autophagic vesicles when examined via electron microscopy. 
Autophagy was further assessed in LIP expressing cells by monitoring the 
development of acidic vesicular organelles and conversion of LC3 from the 
cytoplasmic form to the membrane-bound form.  Although the mechanism by 
which LIP induces autophagy remains unknown, preliminary data suggest that 
the nuclear cofactor, diabetes- and obesity- related gene (DOR), may be 
involved. 
Materials and Methods  
Adenoviral Constructs and Cell lines 
 The adenoviral (Ad) constructs used in these experiments were previously 
constructed and described (Duong et al., 2002).  The human breast cancer cell 
lines MDA-MB-231, MDA-MB-468, and MCF-7 were obtained from the American 
Type Culture Collection (ATCC) (Manassas, VA).  MDA-MB-231 cells and MDA-
MB-468 cells were maintained in Iscove's Modified Eagle media supplemented 
with 10% (v/v) fetal bovine serum (FBS) from HyClone Laboratories (Logan, UT, 
USA), 10 µg/ml bovine insulin, 100 U/ml penicillin, and 100 µg/ml streptomycin 
(Life Technologies, Inc., Carlsbad, CA).  MCF-7 cells were grown and maintained 
in Dulbecco’s Modified Eagles’s medium (DMEM) (Invitrogen, Burlington, ON, 
Canda) supplemented with 10 µg/ml bovine insulin, 100 U/ml penicillin, 100 
µg/ml streptomycin (Life Technologies, Inc., Carlsbad, CA) and 10% (v/v) heat 
inactivated FBS.  All cells were grown at 37°C in a humidified atmosphere 
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containing 5% CO2. 
Cell proliferation assays 
 MDA-MB-231, MCF-7, or MDA-MB-468 cells were grown to subconfluency 
(60–70%) on 100mm dishes.  Cells were either uninfected (NV: no virus) or 
adenovirally (Ad) infected with Ad-green fluorescent protein (GFP) or Ad-LIP at a 
multiplicity of infection (MOI): 5–10.  After 24hrs, cells were trypsinized and 
collected in normal growth media.  Cells were counted with a hemocytometer and 
plated at a density of 1 × 105 cells/mL for the MDA-MB-231 cell line or 2 × 105 
cells/mL for the MDA-MB-468 cell line.  Cells were counted every day for seven 
to nine days.  Cells were replenished with normal growth media every third day.  
Some assays were performed by plating 1 × 106 cells/mL and cells were counted 
every other day. 
 The (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4 
sulfophenyl)-2H-tetrazolium) (MTS) assay was used to monitor cell 
proliferation.  Control (NV and GFP) MDA-MB-468 cells and LIP-expressing 
MDA-MB-468 cells were plated 24hrs post-infection in a 96-well plate at a density 
of 4 × 103 cells per well.  Assays were performed at 2–5 days post-infection by 
adding a small amount of the CellTiter 96® AQueous One Solution Reagent 
(Promega, Madison, WI) directly to culture wells as recommended by 
manufacturer.  This reagent contains an electron coupling reagent phenazine 
methosulfate (PMS) and a tetrazolium compound (inner salt, MTS). 
Dehydrogenase enzymes, found in metabolically active cells, convert MTS into a 
purple insoluble formazan product.  After a 4hr incubation period, absorbance at 
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490nm was measured with a 96-well plate reader. The quantity of formazan 
product as measured by the amount of 490nm absorbance is directly proportional 
to the number of living cells in culture. 
Colony formation assays 
 Control (NV or GFP) and LIP-expressing cells were plated 24hrs post-
infection.  Cells were seeded at different densities (800, 1600, and 3200 cells per 
100mm tissue culture dish) for each condition.  Cells were grown in normal 
growth media and replenished every three days. After 12–20 days in culture, 
plates were rinsed with phosphate-buffered saline (PBS), fixed with 95% (v/v) 
ethanol for 15 minutes at room temperature.  After removing the ethanol, plates 
were stained with Gill No. 3 hematoxylin solution for approximately 1 hour at 
room temperature (Cat. # GHS332-1L; Sigma Chemical Co., St. Louis, MO). 
Plates were then repeatedly rinsed and colonies counted by visual inspection for 
each condition. 
Cell Cycle Analysis 
 DNA cell cycle profiles of sub-confluent (60–70%) cultures were determined 
by flow cytometry using a BD FACScan (Becton Dickinson, San Jose, CA). All 
cultures were harvested at 24, 72, and 96hrs post-infection by trypsinization and 
pelleting in the presence of 20% (v/v) FBS at 500 × g for 7 minutes.  Cells were 
then counted using a hemocytometer.  Approximately 2 × 106 cells were washed 
twice in cold PBS and fixed in ice-cold 70% ethanol overnight.  The samples 
were pelleted at 500 × g for 7 minutes and washed twice with ice-cold PBS. 
Lastly, the cells were incubated in a staining solution containing 2.5 mg/ml 
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RnaseA, 2.0 mg/ml propidium iodide, 0.1% (v/v) Triton X-100, 1 µM 
ethylenediaminetetraacetic acid (EDTA) in 1 × PBS for 30–60 minutes at 4°C in 
the dark. Data was collected using BD Cellquest software (BD Biosciences 
Immunocytometry Systems, San Jose, CA), and cell cycle modeling was 
performed using Modfit software (Verity Software House, Topsham, ME).  The 
cell cycle profile of each population was generated from DNA content data 
collected from between 15,000 to 25,000 separate events. 
Electron Microscopy 
 Control MDA-MB-231 cells or MDA-MB-231 cells infected with Ad-GFP or 
Ad-LIP were fixed with a solution containing 3% (v/v) glutaraldehyde plus 2% 
(v/v) paraformaldehyde in 0.1 M cacodylate buffer (pH 7.3) for 1 hour.  The 
samples were then post-fixed in 1% osmium tetroxide (OsO4) in the same buffer 
for 1 hour.  Samples were then dehydrated in a graded alcohol series and 
embedded in epoxy resin.  Representative areas were chosen for thin sectioning 
and viewed with an electron microscope (JEM 1010 transmission electron 
microscope; JEOL, Peabody, MA). 
Whole cell lysates, cell fractionation, and immunoblot analysis 
 Whole cell lysates were prepared from 100mm dishes of 50–90% confluent 
MDA-MB-231 or MDA-MB-468 cells by scraping the cells at 4°C into (100 mM 
sodium chloride (NaCl), 10 mM Tris pH 8, 1 mM EDTA) (STE) in the presence of 
the following protease/phosphatase inhibitors: (10 µM Na vanadate, 10 mM Na 
molybdate, 10 mM beta-glycerolphosphate, 1 µg/ml aprotinin, 1 µg/ml leupeptin, 
1 µg/ml pepstatin, and 1 mM phenylmethylsulfonyl fluoride).  Nuclear and 
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cytoplasmic extracts were prepared in Buffer A.  An equal volume of 2x sodium 
dodecyl sulfate (SDS) sample buffer and 2-mercaptoethanol (BME) was added 
and samples were boiled for 5 minutes.  Relative protein concentrations were 
determined using Protein Assay Reagent (BioRad Laboratories, Hercules, CA, 
USA) as per manufacturer's instructions.  Equal amounts of protein were loaded 
onto a 10% or an 18% SDS – polyacrylamide gel electrophoresis (PAGE) and 
separated by electrophoresis.  The 18% SDS-PAGE running gel is prepared 
using 24mL of 30%(v/v) acrylamide and 0.15%(v/v) Bis N,N’-methylethylene-bis 
acrylamide, 10mL of 3M Tris pH 8.8, 0.4mL of 10% (v/v) SDS and 0.4ml of 10% 
(w/v) ammonium persulfate in a final volume of 40mL. The stacker gel is 
prepared using 6mL of 10% (v/v) acrylamide and 0.15% (v/v) N,N’-
methylethylene-bis acrylamide, 5mL of 1M Tris pH 6.8, 0.2mL of 10% (v/v) SDS 
and 0.2mL of 10% (v/v) ammonium persulfate in a final volume of 20mL. The 
proteins were transferred to an Immobilon®-P or Immobilon®-FL filter (EMD 
Millipore, Billerica, MA) and the blots were processed as described previously 
(Eaton et al., 2001).  Briefly, the nonspecific binding sites were blocked with 5% 
(w/v) nonfat dried milk (NFDM) in Tris Buffered Saline (TBS-T: 100 mM Tris pH 
7.5, 150 mM NaCl, and 0.05% Tween-20).  Then blots were incubated with 
primary antibodies: MAP1-LC3 at a 1:1,000 dilution overnight (Cat. # PD012, 
MBL, Woburn, MA), Caspase-3 at a 1:1,000 dilution overnight (sc-9662 Cell 
Signaling, Boston, MA), TP53INP2/DOR at a 1:1,000 dilution overnight (cat. # 
T1879, Epitomics, Burlingame, CA) T7-tag at a 1:20,000 dilution (EMD 
Bioscience, San Diego, CA) in TBS-T containing 0.5% (w/v) NFDM for 1 hour at 
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room temperature with gentle agitation.  The blots were detected with a horse 
radish peroxidase (HRP)-conjugated goat anti-mouse or anti-rabbit antibody (Cell 
Signaling, Boston, MA).  Signal was detected by chemiluminescence using 
SuperSignal West Pico reagent (Pierce, Rockford, IL, USA).  Alternatively, the LI-
COR ODYSSEY infrared imaging system (Lincoln, Nebraska) was used for 
immunoblot analysis and quantitation as per manufacturer’s instruction. 
Indirect immunostaining and image acquisition 
 Endogenous high mobility group box 1 (HMG1) and LC3 were detected in 
control (NV, GFP) and LIP-expressing MDA-MB-468 cells.  All MDA-MB-468 cell 
cultures were grown in 35mm dishes fitted with collagen-coated glass coverslips 
(MatTek Corp, Ashland, MA, USA).  Cultures were washed three times in PBS, 
fixed in 3.7% (v/v) formalin in PBS for 30 minutes at room temperature, washed 
an additional three times, and processed for indirect immunofluorescence.  The 
cells were washed at least three times in PBS after each treatment.  First, the 
cells were permeabilized in PBS containing 0.1% (v/v) Triton X-100 for 20 
minutes at room temperature.  The cells were washed and nonspecific binding 
sites were blocked in PBS containing 5% (w/v) bovine serum albumin (BSA) 
(Fraction V, Sigma Chemical Co., St. Louis, MO) at 4°C for 24hrs.  Immediately 
following aspiration of the blocking solution, the cells were incubated with HMG1 
polyclonal antibody (Cat. # 10829-1-AP, Proteintech Group, Chicago, IL) at a 
dilution of 1:75 or LC3B polyclonal antibody (Cat. # NB600-1384, Novus 
Biologicals, Littleton, CO) at a dilution of 1:150 in PBS containing 2% (w/v) BSA 
and 0.1% (v/v) Triton X-100 for 2hrs at room temperature.  The cells were 
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washed as described above.  Cells were then incubated for an additional hour at 
room temperature in the dark with fluorescent-conjugated Alexa 594 goat-anti-
rabbit secondary antibody diluted to a final concentration of 2 µg/ml in PBS 
containing 2% (w/v) BSA and 0.1% (v/v) Triton X-100.  The cells were then 
washed three times in PBS containing 0.1% (v/v) Triton X-100 and a few final 
rinses with double-distilled water.  In some cases, Hoechst 33342 (Sigma-Aldrich 
Co., St. Louis, MO) was used to label the nucleus.  The cells were visualized on 
a Leica DM IRB inverted fluorescence microscope equipped with a Nikon DMX 
1200C digital camera. 
Quantification of Acidic Vesicles by Acridine Orange using Flow Cytometry 
 Control (NV, Ad-GFP) MDA-MB-231 cells and Ad-LIP MDA-MB-231 cells 
were stained with acridine orange 96hrs post-infection.  Cells were trypsinized 
and prepared from 100mm dishes.  Acridine orange (Polyscience, Warrington, 
PA) was added at a final concentration of 1µg/mL for a period of 15 minutes at 
room temperature.  Cells were washed and collected in 1x PBS.  Following 
quantification on a hemocytometer, approximately 1 × 106 cells were stained and 
then analyzed by flow cytometry.  Data was collected using BD Cellquest 
software (BD Biosciences Immunocytometry Systems, San Jose, CA).  Red 
(>650nm) fluorescence emission from 106 cells illuminated with blue (488nm) 
excitation light was measured with a BD FACScan (Becton Dickinson, San Jose, 
CA).  Winlist software (Verity Software House, Topsham, ME) was used to 
determine the fluorescence means and make the overlays.  The profile of each 
population was generated from data collected from a representative sample of 
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25,000 events.  Five separate experiments were performed. 
Statistical analysis 
Quantitative data are expressed as means ± standard deviation (SD).  For 
comparisons between multiple groups, ANOVA followed by the Student-
Newman-Keuls multiple comparisons test was used.  Prism 5.0 (GraphPad, La 
Jolla, CA) was used for all analyses. 
Results 
LIP expression attenuates proliferation of the MDA-MB-468 breast cancer 
cell line 
We have previously demonstrated that overexpression of LIP in the 
MCF10A cell line is incompatible with cell proliferation (Bundy et al., 2005).  
When attempting to generate a population of LIP-expressing cells by infection 
with the chimeric retrovirus, LZRS-HisLIP-IRES-GFP, followed by cell sorting, we 
found we could not establish a cell population stably expressing elevated LIP.  
We reasoned adenovirally infecting the cells would eliminate the problematic 
expansion of sorted cells when LIP is growth inhibitory.  To analyze the effect of 
LIP expression, we used an adenoviral vector to transduce the breast cancer cell 
line, MDA-MB-468, with the truncated C/EBPbeta gene comprising the C-
terminal half encoding a T7-epitope tagged 20kDa LIP protein.  The adenoviral 
vector also encodes a GFP marker protein so that infected cells are easily 
detected by their green fluorescence; as such control adenoviral vector  
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Figure 6. LIP expression attenuates proliferation of the MDA-MB-468 breast 
cancer cell line.  A, Fluorescent micrographs are shown for a, NV; b, GFP; and 
c, LIP cells.  Corresponding brightfield micrographs of control d, NV or e, GFP 
cells are shown.  Brightfield micrographs of LIP cells are shown in panel f.  Cells 
were plated on day 1 post-infection at the same density (2 × 106 per 100 mm 
dish); images were taken 3 days post-infection.  B, MDA-MB-468 cells infected 
with Ad-LIP (▲) or Ad-GFP (■) and compared to NV (●) control cells.  Cells were 
plated on day 1 post infection at 200,000 cells per 100 mm dish and counted 
every day.  Results are shown as the mean of three experiments.  Error bars 
represent the standard deviation (SD).  *p<0.05; **p<0.01; ***p<0.001 comparing 
the Ad-LIP to the control (NV and Ad-GFP) MDA-MB-468 cells.  #p<0.05; 
#p<0.01 comparing the controls (NV and Ad-GFP) MDA-MB-468 cells.  C, 
Representative plates with visible colonies from colony formation assays of 
control (NV, GFP) and LIP MDA-MB-468 cells.  D, The proliferative activity of 
MDA-MB-468 cells infected with LIP (▲), GFP (■), and NV (●) control cells was 
assessed by the MTS assay.  Cells were plated on day 1 post infection at 4 × 103 
cells per well.  Data are the mean ± SD of three separate experiments.  *p<0.05; 
**p<0.01 comparing the LIP to the control (NV and GFP) MDA-MB-468 cells.  E, 
Cell extracts were prepared from MDA-MB-468 NV cells (lanes 1–3), Ad-GFP 
cells (lanes 4–6), and Ad-LIP cells (lanes 7–9) at days 2, 4, and 6 post-infection. 
Expression of T7-tagged LIP was determined by immunoblot analysis using anti-
T7 epitope tag antibody.  GAPDH is shown as a loading control. 
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expressing GFP only was also used.  Cells were plated at the same density and 
adenovirally infected with control Ad-GFP or Ad-LIP on day 0.  Uninfected or no 
virus (NV) control cells are used in our experiments to compare to adenoviral 
infected cells.  Adenoviral infection efficiency was approximately 90% for the 
GFP only infected cells and >95% for the LIP-GFP infected cells (Fig. 6A panels 
a–c).  Photomicrographs of the MDA-MB-468 cells in culture three days post-
infection are shown in Figure 6A.  The NV MDA-MB-468 cells and Ad-GFP MDA-
MB-468 cells continue to proliferate (Note the control cell cultures are >90% 
confluent three days after plating).  LIP-expressing cells, however, are unable to 
proliferate in culture leading to a decrease in cell density in comparison to the 
control cells (Fig. 6A, panel c and f).  
To quantitate and monitor the decrease in cell density, cell counts were 
performed daily for 9 days post-infection.  LIP expression in MDA-MB-468 cells 
leads to a decrease in cell number (Fig. 6B) after several days post-infection, 
demonstrating that LIP overexpression results in cell death.  Next, I performed  
colony formation assays with MDA-MB-468 cells.  These assays are based on 
the principle that stable expression of certain proteins cause either cell cycle 
arrest or cell death, thus there is a reduction in colony number.  Control MDA-
MB-468 cells (NV and Ad-GFP) were able to produce significantly more colonies 
than the LIP-expressing MDA-MB-468 cells (Fig. 6C).  I further examined the 
proliferation of control (NV, Ad-GFP) and (Ad-LIP) MDA-MB-468 cells by 
performing MTS assays.  LIP expression results in inhibition of the proliferative 
activity of MDA-MB-468 cells to 20–40% of control cells at days 4 and 5 post-  
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Figure 7. LIP expression attenuates proliferation of the MDA-MB-231 breast 
cancer cell line.  A, Fluorescent micrographs are shown for control a, uninfected 
(NV); b, Ad-GFP; and c, Ad-LIP cells.  Corresponding brightfield micrographs of 
NV cells or Ad-GFP cells and Ad-LIP cells are shown in panels d-f, respectively.  
MDA-MB-231 cells were adenovirally infected at an MOI of 10.  Cells were plated 
on day 1 post-infection at the same density (1 x 106 per 100 mm dish) and 
images were taken three days post-infection.  B, MDA-MB-231 cells were 
infected with Ad-LIP (▲) or Ad-GFP (■) and compared to NV (●) control cells.  
Cells were plated on day 1 post-infection at 100,000 cells per 100 mm dish and 
counted every day.  Results are shown as the mean of three experiments.  Error 
bars represent the standard deviation (SD).  *p<0.05; **p<0.01; ***p<0.001 
comparing the Ad-LIP to the control (NV and Ad-GFP) MDA-MB-231 cells. 
#p<0.05; #p<0.01 comparing the controls (NV and Ad-GFP) MDA-MB-231 cells. 
C, MDA-MB-231 cells (NV, Ad-GFP, or Ad-LIP) were plated into 100mm dishes 
at a density of 3200 cells per dish.  Colonies were scored by counting visible 
colonies after 12 days and are presented as the mean value ± standard deviation 
from three individual experiments.  *p<0.05; **p<0.01 comparing Ad-LIP to the 
control (NV and Ad-GFP) MDA-MB-231 cells.  D, Cell extracts were prepared 
from MDA-MB-231 Ad-LIP cells (lanes 1-3), Ad-GFP cells (lanes 4-6), and NV 
cells (lanes 7-9) at days 2, 4, and 6 post-infection.  Expression of T7-tagged LIP 
was determined by immunoblot analysis using anti-T7 epitope tag antibody. 
GAPDH is shown as a loading control. 
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infection (Fig. 6D).  To confirm LIP expression, I conducted immunoblot analysis 
of whole cell lysates using anti-T7 antibody.  As shown in Figure 6E, we initially 
detect a high level of the T7-tagged 20kD LIP protein at day 2 post-infection in 
LIP expressing cells that remain attached to the plate.  However, LIP levels 
decline at day 4 post-infection and are undetectable by immunoblot analysis at 
six days post-infection.  These results show that cells expressing LIP do not 
proliferate and are lost from the population. 
LIP expression attenuates proliferation of the MDA-MB-231 breast cancer 
cell line 
To extend our findings in other breast cancer cell lines, LIP was 
introduced into MDA-MB-231 and MCF-7 cells and cell proliferation was 
monitored. Photomicrographs of the MDA-MB-231 cells in culture three days 
post-infection are shown in Figure 7A.  In the same way, the Ad-LIP MDA-MB-
231 cells are dying or unable to proliferate in culture leading to a decrease in cell 
density in  
comparison to the control cells (Fig. 7A, panel c and f).  Cell density was 
monitored by plating cells at the same density post-infection and counted every 
day (MDA-MB-231) or every other day (MCF-7 cells).  LIP expression inhibited 
cell proliferation in MDA-MB-231 (Fig. 7B) and MCF-7 cells (Figure 8). 
Colony formation assays were also performed with the MDA-MB-231 cells. 
Likewise, the LIP-expressing MDA-MB-231 cells formed fewer colonies than the 
control (NV and Ad-GFP) MDA-MB-231 cells (Fig. 7C).  LIP expression in the 
MDA-MB-231 was confirmed by immunoblot analysis using the anti-T7 antibody.  
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Figure 8. LIP expression attenuates proliferation of MCF-7 breast cancer 
cell line.  MCF-7 cells were adenovirally infected with Ad-LIP (▲) or Ad-GFP (●) 
and compared to NV (■) control cells.  Cells were plated on day 1 post-infection 
at the same density (1 x 106 per 100 mm dish) and counted every other day.  
Results are shown as the mean of three experiments.  Error bars represent the 
standard error (SE).   
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We detect LIP expression at day 2 post-infection; however, LIP levels 
rapidly decline and are undetectable after four days post-infection (Fig. 7D). 
Interestingly, at day 6 this cell population is beginning to recover, coinciding with 
the loss of overexpressed LIP protein. 
LIP does not block cell cycle progression or induces apoptosis 
 We considered that LIP expression might inhibit proliferation by blocking 
the cell cycle or by inducing apoptosis, since we observe a decrease in cell 
number in the LIP-expressing cell population and lower to almost no colony 
formation.  To address these possibilities, cell cycle analysis and caspase-3 
activation assays were performed on the MDA-MB-231 cell line. Fluorescence- 
activated cell sorting (FACS) analysis was performed at various time points (days 
1, 3, and 6 post-infection) and revealed no significant differences in the cell cycle 
phases (Fig. 9A and B).  Ad-LIP infected cells did not show a G1 phase arrest 
and LIP-expressing cells are present in the G2/M phase as well as the S-phase 
(Fig. 9A panel c).  We can conclude that Ad-LIP does not block cell cycle 
progress.  Interestingly, a sub-G1 phase (arrow in Fig. 9A panel a–c), a 
characteristic of apoptosis, was not detected in Ad-LIP infected cells.  To confirm 
the absence of apoptosis, I examined caspase-3 activation in the Ad-LIP infected 
cells.  Activation of caspase-3 is key in mediating apoptosis (Cohen, 1997).  
Activation requires proteolytic processing of its inactive zymogen into activated 
p17 and p12 fragments (Cohen, 1997).  Caspase-3 activation was screened in 
MDA-MB-231 cells by western blotting (Fig. 9C).  LIP-expressing cells did not 
activate caspase-3 at a low or higher MOI as indicated by the absence of the  
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Figure 9. LIP does not block cell cycle progression or induce apoptosis.  A, 
Cell cycle profiles of a, uninfected NV MDA-MB-231 cells, b, Ad-GFP cells, and 
c, Ad-LIP cells.  Results from a representative experiment are shown.  B, 
Quantification of cell cycle analysis of MDA-MB-231 cells at day 6 post-infection. 
Solid black bars indicate the percentage of cells in G0/G1, gray-filled bars the 
percentage in S-phase, and yellow-filled bars the percentage in G2-M.  C, Whole 
cell lysates were prepared from control NV (lane 1) and Ad-GFP MDA-MB-231 
cells (lane 2) at day 3 post-infection.  Whole cell lysates were also prepared from 
MDA-MB-231 cells infected with Ad-LIP at a MOI of 10 or 30 (lanes 4-9) at 
different time points (days 3, 5, and 7) post-infection.  RKO colon cancer cell line 
treated with 5-fluorouracil (lane 3) is included as a positive control.  Samples 
were analyzed by 12% SDS-PAGE and immunoblot analysis for caspase-3 
activation was performed.  Equal amounts of total protein were loaded in each 
lane as determined by Ponceau S staining. 
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Figure 10. LIP expression does not induce caspase-3 activation.  Whole cell 
lysates were prepared from control NV (lane 1), Ad-GFP MDA-MB-468 cells 
(lane 2), Ad-LIP MDA-MB-468 cells (lane 3) infected at a MOI of 10.  Lane 4 is a 
positive control for caspase-3 activation.  Lysates were prepared at day 3 post-
infection.  Samples were analyzed by 12% SDS-PAGE and immunoblot analysis 
for caspase-3 activation was performed.  Equal amounts of total protein were 
loaded in each lane as determined by Ponceau S staining. 
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cleaved caspase fragments (Fig. 9C lanes 4–9) that are present in the positive 
control (Fig. 9C Lane 3).  Activation of caspase-3 was also screened in MDA-MB- 
468 cells (Figure 10) and caspase-3 activation was not detected.  Furthermore, 
chromatin condensation and nuclear breakdown was not observed in the 
ultrastructural analysis of these cells as illustrated in Figure 12.  Collectively, 
these results indicate that Ad-LIP does not induce apoptosis. 
LIP does not induce necrosis 
In contrast to apoptosis, necrotic cell death is not a developmentally 
programmed type of cell death.  Necrosis takes place when cells are exposed to 
extreme stress conditions, which leads to a deregulation of normal cellular 
activities.  High mobility group box 1 (HMG1) is a non-histone nuclear protein 
participating in chromatin architecture and transcriptional regulation (Degryse et 
al., 2001).  However, it is also secreted from damaged or necrotic cells (Degryse 
et al., 2001).  In order to test whether LIP expression was inducing necrotic cell 
death, I assayed the intracellular localization of HMG1 in the MDA-MB-468 cells 
by immunostaining.  MDA-MB-468 cells were forced into necrosis by treatment 
with deoxyglucose and azide.  HMG1 is no longer localized to the nucleus of 
these cells as shown in Figure 11 (left panel).  Under normal conditions, HMG1 is 
localized to the nucleus as seen in control (NV and Ad-GFP) MDA-MB-468 cells.  
More importantly, LIP expression does not lead to secretion of HMG1.  We detect 
HMG1 in the nucleus of the LIP-expressing MDA-MB-468 cells.  I repeated these 
experiments at days 3, 4, and 6 post-infection and did not detect any changes in 
the HMG1 localization. 
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Figure 11. LIP does not induce necrosis.  MDA-MB-468 cells were induced 
into necrosis by adding 6mM deoxyglucose plus 10mM sodium azide for 18hrs 
and used as a positive control.  Immunofluorescence studies were performed on 
MDA-MB-468 cells (NV, Ad-GFP, or Ad-LIP) at day 4 post-infection.  Cells were 
fixed and stained for DNA (Hoechst top panel) and HMG1 (middle panel).  GFP 
positive cells are shown (bottom panel).  
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Ultrastructure of autophagic vesicles (AV) formed during LIP-induced 
autophagy 
Interestingly, when examining the LIP-expressing cells under the light 
microscope, the dying/dead cells exhibited a change in cell morphology with  
increased intracellular vacuoles.  Given the vacuolated appearance of the MDA-
MB-231 cells infected with Ad-LIP, we wanted to confirm if autophagy was 
occuring using electron microscopy.  Autophagy can be observed through 
ultrastructural analysis using transmission electron microscopy (TEM) (Klionsky 
et al., 2007).  This method is one of the most indispensable methods to detect 
autophagic compartments in mammalian cells (Klionsky et al., 2007).  LIP-
expressing MDA-MB-231 cells, displayed in Figure 12A (panel c), show a 
dramatic amount of autophagic vesicles (AV) not seen in the control (NV and Ad- 
GFP) MDA-MB-231 cells (Fig. 12A panel a and b, respectively).  The magnified 
images illustrate autophagosomes with characteristic double or multiple 
membranes (Fig. 12B panel a, b).  These autophagosomes contain engulfed 
materials, including degraded cytoplasmic areas, as well as organelles.  In 
addition, there are many multi-lamellar structures observed (Fig. 12B panel b). 
Empty vacuoles were also identified (Fig. 12B panel c) that are not likely to be 
autophagic, although their significance is unknown. In addition, electron 
microscope (EM) micrographs reveal “myelin” bodies (Fig 12B, panel d), which is 
the end result of extensive autophagy.  These EM micrographs provide strong 
evidence that LIP induces autophagy in MDA-MB-231 cells. 
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Figure 12. Ultrastructure of autophagic vacuoles (AV) formed during LIP-
induced autophagy.  A, Representative electron micrographs shown of a, 
uninfected NV MDA-MB-231 cells; b, Ad-GFP MDA-MB-231 cells; and c, Ad-LIP 
MDA-MB 231 cells 2 days post-infection.  B, Electron micrographs of LIP-
expressing MDA-MB-231 cells at later stages (six days post-infection) of 
autophagic process.  Scale bar: A, 2 micron (a–c); B, 500nm (a,b); 2 micron (c); 
100nm (d). 
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Figure 13. LIP overexpression leads to increase of autophagic vacuoles 
(AV).  LIP-induced appearance of AV was detected by staining with the 
lysosomotropic agent, acridine orange.  Cells were stained and processed for 
flow cytometric analysis.  Mean red fluorescence was determined as described in 
“Materials and Methods”.  A, Panel a shows an overlay comparing the control NV 
and Ad-LIP MDA-MB 231 cells.  Panel b shows an overlay comparing the control 
NV and Ad-GFP MDA-MB-231 cells.  B, Quantitation of red fluorescence 
(>650nm) for control NV, Ad-GFP, or Ad-LIP MDA-MB-231 cells four days post- 
infection.  Results are shown as the mean of 5 separate experiments.  Error bars 
indicate ± standard error of the mean (SEM).  (*p-value<0.01). 
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LIP overexpression leads to increase acidic vesicles 
Autophagy can also be monitored by the development of acidic vesicular 
organelles (Klionsky et al., 2007).  Acidification of autophagic vesicles is 
mediated by the vacuolar H+-ATPase in yeast or lysosomal hydrolases in 
mammalian cells.  The lysosomotropic agent acridine orange is a weak base that  
moves freely across biological membranes when uncharged.  Its protonated form 
accumulates in acidic compartments (Paglin et al., 2001).  Therefore, it can be 
used to quantify acidic AV accumulation.  When compared to control uninfected 
MDA-MB-231 cells, the Ad-LIP cells show a shift or increase in the red 
fluorescence.  Interestingly, we also detect a side plateau indicative of dying cells 
(arrow in Fig. 13A panel a).  There are no changes detected in the control (NV 
and Ad-GFP) MDA-MB-231 cells (Fig. 13A panel b).  The results of five separate 
experiments were quantitated as shown in Figure 13B.  In comparison to the 
controls, NV and Ad-GFP MDA-MB-231 cell populations, LIP-expressing cells 
were determined to have a statistically significant (p<0.01) increase in acidic 
vesicles (Fig. 13B).  There was no statistical difference between the NV and Ad-
GFP MDA-MB-231 cells.  After performing these experiments at various time 
points, we detect the greatest changes in acridine orange staining four days post-
infection. 
LIP-induced activation of LC3 
Induction of autophagy by LIP was also confirmed by LC3 activation.  LC3 
is the first mammalian protein known to specifically associate with the 
autophagosomes (Kabeya et al., 2000).  LC3 binds the elongating  
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Figure 14. LIP-induced activation of LC3.  A, Whole cell lysates were prepared 
from control uninfected NV MDA-MB-468 cells (lanes 3,6,9, and 12), Ad-GFP 
MDA-MB-468 cells (lanes 1,4,7, and 10), and Ad-LIP MDA-MB-468 cells (lanes 
2,5,8, and 11) at different time points (days 2–5) post-infection and analyzed by 
18% SDS-PAGE.  Immunoblot analysis with anti-LC3 antibody and a B-tubulin 
antibody (used as a loading control) is shown.  LC3-I, soluble form of LC3; LC3-
II, membrane-bound form of LC3.  B, Densitometric analysis of LC3-II in MDA-
MB-468 cells using the ODYSSEY infrared imaging system.  Data shown 
represents the mean ± SEM.  White-filled bars represent the uninfected NV 
MDA-MB-468 cells, shaded bars the Ad-GFP MDA-MB-468 cells, and the solid 
black bars the Ad-LIP MDA-MB-468 cells.  C, LC3 immunostaining (red) of 
control NV, Ad-GFP, or Ad-LIP MDA-MB-468 cells are shown.  The percentage 
of cells with LC3 punctate staining relative to the total cell number at day 4 post-
infection is shown in the corner of each panel (mean ± SD). 
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preautophagosomal membrane after activation by proteolytic cleavage and 
conjugation of a phosphatidylethanolamine molecule to the exposed C-terminus 
(Kabeya et al., 2000; Geng and Klionsky, 2008).  The proteolytic cleavage 
converts LC3 from an 18kD (LC3-I) to a 16kD (LC3-II) protein (Kabeya et al., 
2000).  The conversion of soluble form of LC3 (LC3-I) to the autophagosome- 
associated (LC3-II) is a well-accepted method for monitoring the onset of 
autophagy (Klionsky et al., 2007).  To improve separation of these two small 
proteins I performed immunoblotting after analyzing protein extracts on an 18% 
non-Laemmli acrylamide gel.  We detect an increase in the membrane-bound 
form (LC3-II) in LIP-expressing MDA-MB-468 cells beginning at day 3 post-
infection (Figure 14A lane 5).  LC3-II levels greatly increase at days 4 and 5 post-
infection in LIP-expressing cells (Figure 14A lanes 8 and 11) in comparison to the 
control (NV and GFP) MDA-MB-468 cells (Figure 14B).   
In addition to immunoblot analysis, I assayed the intracellular localization 
of endogenous LC3 in MDA-MB-468 cells using indirect immunostaining and 
fluorescence microscopy.  LC3 has been reported to localize to punctate-
structures when the process of autophagy is occurring.  The NV and Ad-GFP 
MDA-MB-468 cells show dispersed LC3 staining (Figure 14C). Even under 
nutrient-rich conditions, we detect punctate LC3 staining in 43% of LIP-
expressing cells (Figure 14C).  Our results indicate that LIP expression leads to 
an increase in endogenous LC3-II levels and an increase in punctate LC3 
staining reflective of an increase in autophagosomes or autolysosomes. 
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Figure 15. LIP-induced DOR nuclear to cytoplasmic translocation.  Nuclear 
and cytoplasmic fractions were prepared from control uninfected LIP MDA-MB-
468 cells, Ad-GFP MDA-MB-468 cells, and uninfected NV MDA-MB-468 cells at 
72hrs and 96hrs post-infection and analyzed by 12% SDS-PAGE.  Immunoblot 
analysis was performed with anti-DOR antibody.  Equal amounts of total protein 
were loaded in each lane as determined by Ponceau S staining. 
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LIP expression leads to diabetes- and obesity related (DOR) protein 
translocation 
The diabetes- and obesity- regulated protein (DOR), a nuclear cofactor of 
thyroid hormone receptors (THR), is expressed abundantly in metabolically 
active tissues (Baumgartner et al., 2007).  Mauvezin et al recently reported a role 
for DOR in regulating autophagy. This work showed that DOR shuttles between 
the nucleus and the cytoplasm, depending on cellular stress conditions, and re-
localizes to autophagosomes upon autophagy activation (Mauvezin et al., 2010).    
I examined DOR localization by immunoblot analysis (Figure 15). I was able to 
demonstrate elevated levels of DOR in the cytoplasm of LIP-expressing cells 
beginning at 72hrs post-infection, with a substantial increase at 96hrs post-
infection. These results suggest that at least the stimulation of autophagy by LIP 
may involve alterations in DOR localization.   
 
Discussion 
The exact mechanisms controlling induction of autophagy in eukaryotic 
cells are not clearly understood but it appears that induction of autophagy 
involves both transcriptional and post-transcriptional steps.  In this study, I set out 
to demonstrate a role for LIP in stimulating autophagy and inducing cell death in 
breast cancer cell lines.  We had previously found that exogenous LIP 
expression is incompatible with MCF10A cell proliferation, since the initially LIP-
expressing, GFP positive cells rapidly disappear from a mixed population of LIP-
expressing and non-expressing cells (Bundy et al., 2005).  Cell cycle profiling, 
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ultrastructural analysis, and caspase-3 immunoblot analysis performed here 
reveal that LIP expression did not lead to a cell cycle block and apoptotic cells 
are not observed (Figure 9, 10).  I examined whether LIP expression leads to 
necrotic cell death and determined this is not the case (Figure 11).  In contrast, 
ultrastructural analysis using electron microscopy showed a marked induction of 
autophagy in LIP-expressing cells with the accumulation of autophagic vesicles 
(Figure 12).  The induction of autophagy was also confirmed by quantification of 
lysosomal induction as well as the analysis of endogenous LC3 by Western 
blotting and immunofluorescence (Figure 13 and 14).  Finally, I was able to 
demonstrate that stimulation of autophagy by LIP leads to elevated levels of 
DOR in the cytoplasm (Figure 15). Overall, the data presented provide strong 
evidence that expression of the transcription factor, LIP, leads to the induction of 
autophagy and cell death. 
C/EBP transcription factors are involved in a variety of physiological 
processes, such as metabolic regulation, cellular differentiation, and stress 
responses.  The expression of the C/EBP beta gene has been shown to increase 
during endoplasmic reticulum (ER) stress. In recent years, emerging data 
indicate that ER stress is a strong inducer of autophagy (Høyer-Hansen M and 
Jäättelä, 2007).  Interestingly, Li et al. describe increased LIP levels during the 
late phase of ER stress (Li et al., 2008).  Recently, Meir et al. examined the 
distinct roles that LAP and LIP isoforms play in ER stress (Meir et al., 2010). 
They find that LIP augments ER stress-induced cell death in mouse B16 
melanoma cells.  In addition, LIP inhibited B16 melanoma tumor progression 
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(Meir et al., 2010).  Although both of these studies did not examine any markers 
of autophagy, elevated LIP may be one way of linking ER stress and the 
induction of autophagy.  It is interesting that LC3-II levels are highest at 4–5 days 
post-infection with Ad-LIP while the highest levels of LIP are present at 2–3 days 
post-infection.  It is possible that LIP is repressing or downregulating genes 
whose products inhibit autophagy.  Thus, the half-life of such proteins will 
determine the kinetics of when elevated LC3-II is observed.    
As mentioned above, DOR was identified as a nuclear cofactor of thyroid 
hormone receptors (Baumgartner et al., 2007). It is well known that thyroid 
hormones (TH) influence various physiological processes including development, 
cell cycle progression, as well as maintaining metabolic homeostasis 
(Baumgartner et al., 2007). Using various cancer cell line models (e.g., breast, 
pancreas, thyroid), TH has been shown to induce proliferation (Glinskii et al., 
2009; Verga Falzacappa et al., 2007; Lin et al., 2007; 2009;).  Notably, DOR has 
been shown to enhance the transcriptional activity of thyroid hormone receptor 
alpha 1 TR (alpha1) (Baumgartner et al., 2007).  Additionally, DOR was shown to 
regulate autophagy in mammalian cells by shuttling between the nucleus and the 
cytoplasm and localizing to autophagosomes upon autophagy activation 
(Mauvezin et al., 2010).  Our studies show a substantial increase in cytoplasmic 
DOR protein levels in LIP-expressing cells (Figure 15).  We know LIP localizes to 
the nucleus; therefore, one possible mechanism for autophagy stimulation by LIP 
expression may involve DOR displacement from the nucleus to the cytoplasm. 
Following LIP expression, DOR shuttles to the cytoplasm where it may interact 
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with autophagic proteins and regulate autophagosome formation. In addition, 
when DOR localizes to the cytoplasm it can no longer function as a THR cofactor 
and enhance THR transcriptional activity. This may result in a decrease in cell 
proliferation similar to what we observe upon LIP expression (Figures 6-8).  
Our finding that LIP expression induces autophagy may help to resolve 
the paradox over whether LIP is pro- or anti- tumorigenic.  This is because 
autophagy is generally thought to play dual roles in cancer development.  For 
instance, allelic loss of beclin1, an essential autophagy gene, is found with high 
frequency in human ovarian, prostate, and breast cancers (Liang et al., 1999; Qu 
et al., 2003).  BECN +/- mice develop spontaneous tumors including lymphomas, 
hepatocellular carcinomas, lung carcinomas, as well as precancerous lesions in 
the mouse mammary glands.  In addition, autophagy-related 4C (Atg4C)-
deficient mice have an increase in tumor incidence (Qu et al., 2003; Mariño et al., 
2007).  Also, tumor suppressor gene products such as p53, phosphatase and 
tensin homolog (PTEN), death-associated protein kinase-1 (DAPK) and 
tuberous sclerosis (TSC1/TSC2) exert a stimulatory effect on autophagy. 
Moreover, the products of common oncogenes, such as B cell lymphoma-2 (Bcl-
2), class I phosphatidylinositol 3-kinase (PI3K), protein kinase B (PKB), and 
target of rapamycin (TOR) act as autophagy repressors.  Autophagy plays an 
important role in sustaining organelle and protein quality control, working 
alongside with the ubiquitin degradation pathway to prevent the accumulation of 
polyubiquinated and aggregated proteins (Williams et al., 2006).  By doing so, it 
limits the accumulation of genome damage and suppresses the mutation rate of 
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tumor cells in which the cell-cycle checkpoints have been inactivated (Mathew et 
al., 2007).  Recent studies support that autophagy defends the cell in a bimodal 
fashion by directly eliminating invading pathogens and simultaneously assisting 
the immune system of the host organism to mount a specialized immune 
response against the invader by processing pathogenic antigens for presentation 
to T cells.  These studies all provide a strong case for autophagy as a tumor 
suppressor.  Yet at later stages of tumor development, studies have shown that 
this catabolic process may be a means by which tumor cells survive in response 
to metabolic stress and in hypoxic tumor regions, providing extra time for the 
recruitment of a blood supply via induction of angiogenesis and/or motility and 
invasion (Degenhardt et al., 2006).  Thus, it is possible that some expression of 
LIP could promote cancer by increasing survival of certain cells under stress, 
explaining the slightly increased incidence (9%) of tumors observed in WAP-LIP 
transgenic mice (Zahnow et al., 2001).  
Although it may be difficult to define the physiological role of LIP’s ability to 
induce autophagy, further understanding of the mechanism(s) by which LIP 
expression stimulates autophagy and leads to cell death may provide new 
avenues for inducing this alternative death pathway, especially in tumor cells that 
are resistant to apoptosis. 
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CHAPTER III 
 
C/EBPbeta3 (LIP) and cell engulfment 
Introduction 
There is little doubt that autophagy is a regulated cellular process of self-
cannibalization through the lysosomal degradation pathway (Meijer and 
Codogno, 2004).  There are, however, many questions regarding autophagy as a 
nonapoptotic cell death mechanism (Levine and Yuan, 2005).  Does prolonged 
autophagy play a causal role in cell death or does autophagy merely accompany 
cell death induced by other causes?  Numerous studies report the presence of 
autophagosomes as well as other autophagy markers in dying cells.  Additional 
evidence comes from in vitro experiments where genetic or pharmacologic 
inhibition of autophagy prevented cell death.  These and other studies have been 
the main force behind the idea that autophagy is a nonapoptotic form of 
programmed cell death.  
Alternatively, many argue that autophagy is a cell survival defense 
mechanism that simply fails in its mission.  Others argue that the autophagic 
pathway is simply a garbage disposal mechanism that cleans up remnants of a 
cell that is already committed to die.  While there is evidence that autophagy can 
act as a cell death mechanism especially in cells whose apoptotic machinery is 
impaired, most agree that autophagy is actually a bystander that accompanies 
cell death.  
In the previous chapter, I demonstrate a role for LIP in stimulating 
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autophagy in breast cancer cell lines.  In addition, I show that exogenous 
expression of LIP leads to cell death in different breast cancer cell lines. 
Considering that autophagy may be only a bystander, we wanted to understand 
the mechanism(s) by which LIP overexpression causes cell death in breast 
cancer cells.  In examining all the various cell death processes described in the 
literature to date, we came across the phenomenon of live cell engulfment or cell-
in-cell structures (Overholtzer and Brugge, 2008).  One of the most common and 
well-documented methods that results in the transient appearance of cell-in-cell 
structures is the engulfment of apoptotic cells by phagocytosis.  Phagocytosis 
targets dying or dead cells for engulfment, and is propelled by cytoskeletal 
rearrangements of the engulfing cell in response to signals from the internalized 
cell (Overholtzer and Brugge, 2008).  However, there are other processes that 
were introduced in Chapter 1, such as entosis, emperipolesis, and xeno-
cannibalism that also lead to cell-in-cell structures.  These other processes 
describe the formation of cell-in-cell structures via engulfment of another cell or 
through invasion of one cell into another.  Notably, these processes are distinct 
from phagocytosis in that target cells are viable, with some cells even undergoing 
cell division, and some occasionally escaping from internalization altogether 
(Overholtzer et al., 2007).  Nevertheless, the fate of most engulfed cells is cell 
death.  
In this chapter, I show that autophagy appears to accompany or possibly 
follow the engulfment of neighboring cells by the LIP-expressing cells.  In 2-3 
days up to 30-40% of LIP-expressing MDA-MB-468 cells have engulfed live cells, 
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leading to extensive cell death.  This study demonstrates that expression of a 
specific transcription factor can mediate cell engulfment.  
 
Materials and Methods 
Cell Culture and adenoviral constructs 
The human breast cancer cell line MDA-MB-468 was obtained from the 
ATCC (Manassas, VA).  MDA-MB-468 cells were maintained in Iscove's Modified 
Eagle media supplemented with 10% (v/v) FBS from HyClone Laboratories 
(Logan, UT, USA), 100 U/ml penicillin, 100 µg/ml streptomycin (Life 
Technologies, Inc., Carlsbad, CA), and 10 µg/ml bovine insulin.  Cells were 
grown at 37°C in a humidified atmosphere containing 5% CO2.  The adenoviral 
constructs used in these experiments were discussed in the previous chapter. 
MDA-MB-468 cells were grown to subconfluency (60–70%) on 100mm dishes. 
Cells were either uninfected or adenovirally infected with Ad-GFP or Ad-LIP at a 
MOI: 5–10 for all experiments.  
Cell cycle analysis 
DNA cell cycle profiles of sub-confluent (60–70%) cultures were 
determined by flow cytometry using a BD FACScan (Becton Dickinson, San 
Jose, CA).  Cultures were harvested at 72hrs post-infection by trypsinization and 
pelleting in the presence of 20% (v/v) FBS at 500 x g for 7 minutes. Cells were 
then counted using a hemocytometer. Approximately 2×106 cells were washed 
twice in cold PBS and fixed in ice-cold 70% ethanol overnight.  The samples 
were pelleted at 500 x g for 7 minutes and washed twice with ice-cold PBS. 
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Lastly, the cells were incubated in a staining solution containing 2.5 mg/ml 
RnaseA, 2.0 mg/ml propidium iodide, 0.1% (v/v) Triton X-100, 1 µM EDTA in 
1×PBS for 30–60 minutes at 4°C in the dark.  Data were collected using BD 
Cellquest software (BD Biosciences Immunocytometry Systems, San Jose, CA), 
and cell cycle modeling was performed using Modfit software (Verity Software 
House, Topsham, ME).  The cell cycle profile of each population was generated 
from DNA content data collected from between 20,000 to 30,000 separate 
events. 
Cell Internalization Assays 
MDA-MB-468 cells were grown to subconfluency (60–70%) on 100mm 
dishes.  Cells were either uninfected or adenovirally infected with Ad-GFP or Ad-
LIP. After 24hrs, the uninfected monolayer cultures were stained with fluorescent 
orange or violet CellTracker dyes (SKU# C2927 or C10094, Invitrogen, Grand 
Island, NY) for 1hr at 37°C in serum-free media. After 1hr, cells were replenished 
with normal growth media for 2-3 hrs. Stained cells were then washed three 
times with PBS and trypsinized to a single cell suspension in normal growth 
media.  MDA-MB-468 Ad-GFP and Ad-LIP cells were also trypsinized to a single 
cell suspension and collected in normal growth media. Each population was 
counted with a hemocytometer and mixed in 1:3 (LIP or GFP: stained NV cells) 
ratio.  Cells were either plated on 60mm dishes for FACS analysis or when 
acquiring images cells were plated on 35mm dishes fitted with collagen-coated 
glass coverslips (MatTek Corp, Ashland, MA, USA). In some cases, Hoechst 
33342 (Sigma-Aldrich Co., St. Louis, MO) was used to stain DNA. Images 
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presented in Figure 17 were acquired using a Leica DM IRB inverted microscope 
equipped with a Nikon DXM1200C camera and Metamorph software.  
Electron microscopy 
Control uninfected, Ad-GFP, and Ad-LIP MDA-MB-468 cells were fixed at 
48 and 72hrs post-infection with a solution containing 2.5% (v/v) glutaraldehyde 
in 0.1 M cacodylate buffer (pH 7.3) for 1hr at room temperature.  Samples were 
then refrigerated overnight.  Postfix, staining, sectioning, and TEM were 
performed as described above.  Representative areas were chosen for thin 
sectioning and viewed with an electron microscope (Philips CM-12 transmission 
electron microscope). 
Quantitative cell engulfment assay using flow cytometry 
In these assays, cells were stained and mixed in a ratio of 1:3 as 
described above.  At 24-48hrs post-mixing, cells were trypsinized and collected 
in phenol-red free Iscove’s media.  Cells were collected for flow cytometry 
analysis using a 3-laser FACSCanto II instrument, (Becton-Dickinson, San Jose, 
CA) equipped with standard 5-2-2 filter configuration.  FACSDiVa Software was 
used for data acquisition and analysis.  Inhibition of Rho-associated protein 
kinase (ROCK) was performed with 20-40µM of Y-27632 (EMD, Calbiochem, 
product number 688000) for 36-48hrs post-mix until cell populations were 
prepared for FACS analysis.  
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Phospatidylserine exposure 
Control uninfected MDA-MB-468 cells and Ad-GFP or Ad-LIP infected 
cells were washed twice with cold PBS and then resuspended in 1X Binding 
Buffer at a concentration of ~1 x 106 cells/ml.  Initially, 10X Binding Buffer was 
prepared which consists of 0.1 M HEPES, pH 7.4; 1.4 M NaCl; 25 mM CaCl 2; it 
was diluted to 1X for the experiments.  Briefly, 100 µl of the solution (~1 x 105 
cells) was transferred to a 5 ml culture tube.  Cells were stained with Annexin V 
(Molecular Probes, Life Technologies, Grand Island, NY) and/or the vital dye, 7-
aminoactinomycin D (7-AAD).  MDA-MB-468 cells treated with 10 µmol/L 
cisplatin (Sigma-Aldrich, St. Louis, MO) were used as a positive control.  
Tubes were mixed and incubated for 15 minutes at room temperature in the dark. 
An additional 400 µl of 1X Binding Buffer was added to each tube following 
staining procedure. Samples were analyzed by flow cytometry. 
Transfections  
2 x 105 MDA-MB-468 cells were plated in 35mm dishes fitted with 
collagen-coated glass coverslips (MatTek Corp, Ashland, MA, USA) and 
transfected in complete Iscove’s growth medium with TransIT-LT1 transfection 
reagent (Mirus Bio LLC, Madison, WI) using 5µg of pLZRS-IRES-GFP DNA or 
4µg pLZRS-IRES-GFP DNA and 1µg of pcDNA3.1hisLIP at a 1:1 ratio of 
TransIT-LT1 reagent:DNA according to manufacturer’s instructions.  Cells were 
imaged at 4 or 6 days post-transfection. 
 
 
	   72	  
Indirect immunostaining and image acquisition  
Transfected cells were prepared for immunofluorescence studies as 
described in the previous chapter.  Briefly, MDA-MB-468 cell cultures were 
washed three times in PBS, fixed in 3.7% (v/v) formalin in PBS for 30 min at 
room temperature, washed an additional three times, and processed for indirect 
immunofluorescence.  Cells were permeabilized in PBS containing 0.1% (v/v) 
Triton X-100 for 20 minutes at room temperature.  The cells were washed and 
nonspecific binding sites were blocked in PBS containing 5% (w/v) BSA (Fraction 
V, Sigma) at 4°C for 24 hrs.  Immediately following aspiration of the blocking 
solution, the cells were incubated with beta-catenin polyclonal antibody (Sigma, 
C2206) at a dilution of 1:1,000 in PBS containing 2% (w/v) BSA and 0.1% (v/v) 
Triton X-100 for 2hrs at room temperature.  The cells were washed as described 
above.  Cells were then incubated for an additional hour at room temperature in 
the dark with fluorescent-conjugated Alexa 594 goat-anti-rabbit secondary 
antibody diluted to a final concentration of 2 µg/ml in PBS containing 2% (w/v) 
BSA and 0.1% (v/v) Triton X-100.  The cells were then washed three times in 
PBS containing 0.1% (v/v) Triton X-100 and a few final rinses with double-
distilled water.  The DNA stain, Hoechst 33342 (Sigma-Aldrich Co., St. Louis, 
MO), was used to label the nucleus.  Images were acquired with an Eclipse 
TE2000-E wide-field fluorescent microscope (Nikon) equipped with a 60x, 1.4NA, 
oil immersion lens and a cooled charge-coupled device (CCD) camera by the use 
of Metamorph software. 
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Time-Lapse Microscopy  
Cells were mixed and plated on coverglass bottom dishes (MatTek, 
Ashland, MA) as described above.  At 36hrs post-mix images were acquired 
automatically at multiple locations on the coverslip using a Zeiss LSM 510 
inverted confocal microscope fitted with a 20x objective.  The microscope was 
housed in a custom-designed 37°C chamber with a secondary internal chamber 
that delivered humidified 5% CO2. For Supplemental movies 1 and 2, 
fluorescence images were obtained every 4 minutes for a period of 12-14hrs 
using Zeiss image processing software (LSM 5; Carl Zeiss).  Imaging conditions 
did not adversely affect cell proliferation or viability.  Supplemental movies 3 and 
4 were imaged using an Olympus BX61WI upright microscope fitted with a 40x 
objective.  The microscope was housed in a custom-designed 37°C chamber and 
Volocity (Perkin Elmer) software was used for image acquisition.  
Confocal Microscopy 
To confirm if target cells were completely internalized by host LIP-
expressing cells, cells were imaged using a confocal laser-scanning microscope 
(model LSM 510; Carl Zeiss, Inc.), using a 63x objective.  Optical section series 
were collected with a spacing of 0.4 µm in the z-axis through ~3-µm thickness of 
the cell-in-cell complex.  The images from triple labeling were simultaneously 
collected using a dichroic filter set with Zeiss image processing software (LSM 5; 
Carl Zeiss).  Digital data were exported into Adobe Photoshop for presentation 
and as quick-time movie. 
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Immunoblot analysis of mouse mammary glands 
Mouse mammary gland samples were generously provided by Dr. Fiona 
Yull’s laboratory. Mouse mammary glands were isolated and prepared as 
previously described (Connelly et al., 2007). Relative protein concentrations were 
determined using Protein Assay Reagent (BioRad Laboratories, Hercules, CA, 
USA) as per manufacturer's instructions.  Equal amounts of protein were loaded 
onto a 10% SDS-PAGE gel and immunoblot analysis was performed with an anti-
C/EBPbeta antibody (cat. # sc-150, Santa Cruz, CA) as described above.    
Statistical analysis 
Quantitative data are expressed as means.  For comparisons between two 
groups paired t-test and Wilcoxon matched pairs test was used.  In order to 
compare multiple groups, ANOVA followed by the Student-Newman-Keuls 
multiple comparisons test was used.  Prism 5.0 (GraphPad, La Jolla, CA) was 
used for all analyses. 
Results 
Cell disintegration following exogenous expression of LIP 
In the previous chapter I present a role for LIP in stimulating autophagy 
and causing cell death in breast cancer cell lines.  I evaluated the role of LIP 
overexpression in proliferation, necrosis, and LC3 protein turnover of MDA-MB-
468 cells in particular.  Exogenous expression of LIP in MDA-MB-468 cells leads 
to attenuation of cell proliferation as determined by cell proliferation assays.  
Colony formation assays show a dramatic reduction in colonies formed  
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by LIP-expressing MDA-MB-468 cells.  This suggests overexpression of LIP 
causes cell death.  In order to further characterize the mechanism of cell death 
due to LIP overexpression, I used an adenoviral vector, Ad-LIP, to transduce the 
breast cancer cell line, MDA-MB-468, as previously described. Photomicrograph 
of MDA-MB-468 cells in culture 3 days post-infection are shown in Figure 16.  
Images were taken at the same time point for all control Ad-GFP and Ad-LIP 
cells.  A representative image of the control Ad-GFP MDA-MB-468 cells is shown 
in Figure 16, panel a.  The remaining panels (b-i) capture the heterogeneity we 
observe among Ad-LIP infected cells.  Some cells appear intact (Figure 16, panel 
b), while others appear very vacuolated (Figure 16, panel c).  In addition, we 
observe a high percent of LIP-expressing cells breaking down into a number of 
smaller vesicles (Figure 16, panels d-i).  Some of the vesicles appear to be held 
together by a network of fibers (Figure 16, panel f, g).  These LIP-expressing 
cells will continue to disintegrate until eventually there is only cell debris in the 
culture medium.  
DNA content of LIP-expressing MDA-MB-468 cells 
We had observed that the extent of cell death was most severe in the 
MDA-MB-468 breast cancer cell line in comparison to other breast cancer cell 
lines tested.  To assess whether the dying cells were undergoing apoptosis I 
performed cell cycle profiling on the MDA-MB-468 cells expressing LIP.  A sub-
G1 phase characteristic of apoptotic cell death was not detected; even though I 
show in Figure 16 that cells are disintegrating and there is a clear breakdown into 
vesicles.  Instead, we were surprised to find that LIP-expressing cells (Figure 
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Figure 16. Cell disintegration following exogenous expression of LIP. 
Microscopic examination of cell breakdown.  Equal numbers of MDA-MB-468 
cells were plated for adenoviral infection with either control Ad-GFP or Ad-LIP.  
Representative fluorescent photomicrographs of cells imaged at 72hrs post-
infection are shown.  Panel a represents Ad-GFP MDA-MB-468 cells.  Panels b-i 
represent Ad-LIP MDA-MB-468 cells.  
 
 
 
 
 
 
	   77	  
17A panel c) have a significantly greater DNA content than the control uninfected 
and Ad-GFP MDA-MB-468 cells (Figure 17A panel a and b, respectively).  
Significant portions (>40%) of the LIP-expressing MDA-MB-468 cells have more 
than 2n DNA content at 72hrs post-infection (Figure 17B).  
LIP-expressing MDA-MB-468 cells engulf neighboring cells 
Over several days of examining LIP-expressing cells via microscopy, we 
noticed cells that appeared to be multinucleated as well as cells residing in large 
vacuoles.  Taking this data together with the increase in DNA content, we 
reasoned it was possible for LIP overexpression to stimulate engulfment of 
neighboring cells.  To further investigate this possibility, I took GFP positive LIP-
expressing MDA-MB-468 cells and mixed them with a population of control 
uninfected MDA-MB-468 cells that were labeled with fluorescent CellTracker 
orange dye.  After mixing the populations in a 1:3 ratio, cells were plated and 
observed for 24-48hrs.  Engulfment of neighboring cells was evident beginning at 
36hrs post-mixing.  I acquired fluorescent images of LIP-expressing cells (green) 
that had engulfed anywhere from one to three orange-labeled cells (Figure 18).  
DNA staining shows the appearance of multinucleated cells.  Similar experiments 
were performed with control Ad-GFP MDA-MB-468 cells and this engulfment 
process was rare and occurred at a very low frequency.   
To study engulfment in real time, GFP positive LIP-expressing MDA-MB-
468 cells mixed with uninfected CellTracker-labeled MDA-MB-468 cells were 
analyzed by time-lapse microscopy over a 6 to 14hr period. In work published by 
Overholtzer et al. they describe the entosis process to involve the active invasion  
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Figure 17. DNA content of LIP-expressing MDA-MB-468 cells.  A, 
Representative cell cycle profiles of control uninfected: no virus (NV) (panel a), 
Ad-GFP (panel b), and Ad-LIP (panel c) MDA-MB-468 cells are shown.  The 
experiment was performed at least two separate times.  B, Quantification of the 
percent of cells with greater than 2n DNA content as measured by the area 
marked as R2 in the graphs is presented.  
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Figure 18. LIP-expressing MDA-MB-468 cells engulf neighboring cells. 
GFP positive LIP-expressing MDA-MB-468 cells were mixed with uninfected 
CellTracker orange labeled MDA-MB-468 cells.  Hoechst dye was used to stain 
DNA.  Cells were imaged at 36-48hrs post-mix.  
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of one cell into another (Overholtzer et al., 2007).  As presented in movie 1, we 
see the GFP positive LIP-expressing MDA-MB-468 cell extending its cell 
membrane and wrapping around the orange-labeled cell.  These cells seem to 
battle for quite some time, with the orange cell trying to come out of the GFP 
positive LIP-expressing cell. However, the orange cell is not able to escape, at 
least within the time course of this movie (approximately 12hrs).  In movie 2, 
there are a few green cells in the field that have orange-labeled cells inside.  The 
GFP positive LIP-expressing cells are very active making contacts with 
neighboring cells and forming smaller vesicle-like structures.  During this 
process, a group of GFP positive LIP-expressing cells come into view that have 
internalized orange-labeled cells.  After some time, one of these cells begins to 
disintegrate into smaller vesicles until it eventually fades from the field.  
Interestingly, we were also able to capture a GFP positive LIP-expressing cell 
releasing an internalized orange-labeled cell. This is clearly seen in movie 3 as 
the GFP positive LIP-expressing cell opens and the orange-labeled cell escapes 
or is expelled.  It is difficult to conclude the fate of both of these cells, because 
they appear to detach and disappear from the plane of focus.  In movie 4, the 
GFP positive LIP-expressing cell clearly has engulfed more than one orange-
labeled cell.  One of the labeled cells is able to escape; however after the LIP-
expressing cell rearranges, we see the LIP-expressing cell begin to breakdown 
and take the innermost-labeled cell with it.  Both appear to disintegrate and again 
detach from the plane of focus. 
 It should be noted that GFP positive LIP-expressing cells will also engulf 
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other GFP positive LIP-expressing cells as well.  While we focus on the green 
cells engulfing the orange-labeled cells, this is not meant to imply that there is 
any preference for engulfing labeled orange cells; it is just easier to observe this 
photographically.  Interestingly, we have not observed any GFP positive LIP-
expressing cells inside of control uninfected orange-labeled cells.  The GFP 
positive LIP-expressing cells do not invade the orange-labeled cells, as would be 
expected if the LIP-expressing cells were undergoing entosis.  
Ultrastructure analysis of LIP-mediated cell engulfment 
To gain further confirmation of cell engulfment, TEM analysis was 
performed at 48 and 72hrs post-infection of MDA-MB-468 cells with Ad-LIP.  At 
48hrs we detect LIP-expressing cells extending their membranes and wrapping 
around the edges of neighboring cells (Figure 19 panels a-c).  These engulfing 
intermediate cells appear to be vacuolated and forming cell contacts with the 
neighboring cells.  It is unclear whether adherens junctions are being formed; yet 
fibers and secreted basement membrane can be detected (Figure 19 panels 1- 
2).  Remarkably, the engulfing cell’s nucleus begins to change into a more 
crescent-like shape, characteristic of cannibalistic cells (Sharma and Dey, 2011).  
Figure 19 panels d and e are examples of LIP-expressing cells that present with 
immense vacuoles.  A captured cell that was able to escape may have previously 
occupied these large vacuoles, possibly leaving traces behind, or they could 
represent intake of extracellular fluid.  In Figure 19 panels f-h, it is evident that a 
target cell has been internalized and resides in the large vacuole of the host cell. 
In these images we are able to detect more than one nucleus (Figure 19 panel f).   
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Figure 19. Ultrastructure analysis of LIP-mediated cell engulfment in MDA-
MB-468 cells. Panels a-c, ultrastructure of engulfing intermediates at 48hrs post-
infection; scale bar is 2µm. 1 and 2 indicate higher magnification of cell contacts 
present in panel c. Arrows indicate formation of cell contacts. Scale bar is 100nm 
and 500nm for panel 1 and 2, respectively. Panels d and e show LIP-expressing 
cells that have enormous vacuoles; scale bar is 2µm. Panels f-h illustrate an 
internalized cell at 72hrs post-infection; scale bar is 2µm. Panel g is a higher 
magnification to show the nucleus of engulfing (host) cell and the various 
projections typical of actively phagocytic cells. Panel h depicts the engulfed cell 
inside of the vacuole of the host cell.  
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Figure 19 panels g and h are magnified images that show the nuclei of both cells 
remain intact and the various projections typical of actively phagocytic cells.  We 
had previously shown that LIP could stimulate autophagy in these cells.  
Therefore, it is reasonable to see the presence of highly vacuolated cells as 
those seen in Figure 19 panels d-h.  Taken together, these images provide 
strong evidence that LIP expression leads to the engulfment of neighboring cells 
in the MDA-MB-468 breast cancer cell line. 
Quantitation of LIP-mediated cell engulfment 
In order to acquire quantitative data on the engulfment process, I 
employed FACS analysis.  In these experiments, GFP positive LIP-expressing 
cells were mixed in a 1:3 ratio with control uninfected CellTracker-labeled cells. 
24-48hrs post-mix cells were collected and analyzed by flow cytometry.  We 
monitored green cells that were also positive for orange label. This population 
represents the LIP-expressing cells that have engulfed orange-labeled cells.  As 
mentioned above, green LIP-expressing cells also engulf other green cells. 
However, by mixing the green cells with an excess of orange cells in a 1:3 ratio, it 
is more likely that a green cell will encounter an orange cell to engulf rather than 
another green cell.  Nonetheless, the percent of LIP-expressing cells positive for 
orange label still underrepresents the number of LIP-expressing cells engaged in 
engulfing other cells.  We detected a small percent (6%) of cell engulfment at 
24hrs post-infection. However, as presented in Figure 20A panel a, nearly 25% 
of the Ad-LIP MDA-MB-468 cells engulf orange-labeled cells at 48hrs post-  
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Figure 20. Quantification of LIP-mediated cell engulfment. A, Panel a shows 
the percent of Ad-LIP MDA-MB-468 cells that are double positive for GFP and 
CellTracker label. Panel b shows the percent of control Ad-GFP MDA-MB-468 
cells that are double positive for GFP and CellTracker label.  B, Quantification of 
the percent of GFP positive cells that have engulfed uninfected CellTracker 
labeled cells. Results are shown for 16 different experiments with a p-value of 
<0.0001 using paired t-test and Wilcoxon matched pairs test for statistical 
analysis. C, Quantification of the percent of GFP positive cells that have engulfed 
uninfected CellTracker labeled cells after treatment with 40µM of the ROCK 
inhibitor, Y-27632.  Results are shown for 5 different experiments with a p-value 
of <0.0001 using ANOVA followed by the Student-Newman-Keuls multiple 
comparisons test.  
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mixing.  Meanwhile, only a meager 1.8% of the control AD-GFP MDA-MB-468 
cells engulf an orange-labeled cell (Figure 20A panel b).  These experiments 
were repeated 16 different times and found on average 30% of the LIP-
expressing cells engulf CellTracker-labeled cells (Figure 20B).  This is significant 
relative to control GFP only cells with a p-value of <0.0001.  
LIP-mediated cell engulfment requires Rho 
Because the time-lapse photography of LIP-mediated cell engulfment 
shows considerable changes in the actin cytoskeleton occurring, I examined 
whether Rho signaling, which is a critical regulator of actin, plays a role in the 
engulfment process.  Rho-associated protein kinase (ROCK) proteins, the 
downstream effectors of Rho GTPases, were inhibited with Y-27632.  ROCK 
inhibition resulted in a significant decrease (p-value: <0.0001) of LIP-mediated 
cell engulfment as determined by quanititative FACS analysis of green LIP- 
expressing cells containing CellTracker-labeled cells (Figure 20C).  The Rho-  
ROCK-actin pathway was previously found to be an important regulator during 
entosis (Overholtzer et al., 2007). 
LIP does not appear to stimulate the “eat me” signal  
 As described in chapter 1 of this document, phospatidylserine 
translocation from the inner to outer leaflet of the plasma membrane is referred to 
as an “eat me” signal. PtdSer exposure marks the cell for recognition and 
engulfment by neighboring cells or macrophages. Since we observe LIP-
expressing cells engulfing neighboring cells, we wanted to test whether 
expression of LIP in the MDA-MB-468 cells leads to an increase in PtdSer  
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Figure 21.  LIP does not appear to stimulate PtdSer exposure in MDA-MB-
468 cells. Control MDA-MB-468 cells treated with cisplatin to induce apoptosis. 
MDA-MB-468 cells infected and collected and stained with Annexin V.  Cell 
populations were analyzed by flow cytometry.  Experiments were performed at 
72hrs post-infection. 
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exposure. In comparison to the control cisplatin treated cells that show a high 
percentage of cells positive for Annexin V staining, PtdSer exposure of LIP-
expressing cells does not increase at the 72hrs post-infection time point (Figure 
21). This time point was chosen since it is when we detect changes in DNA 
content (Figure 17) as well as detect the highest percent of cell engulfment 
(Figure 20B). LIP-expression does not appear to stimulate “eat me” signals in 
comparison to the uninfected and Ad-GFP MDA-MB-468 cells.  
LIP-mediated cell engulfment is not dependent on adenoviral infection 
To address concerns regarding whether adenoviral infection is required for 
LIP-mediated cell engulfment, we transfected MDA-MB-468 cells with expression 
vectors for GFP and LIP, or GFP alone.  Cells were observed via fluorescent 
microscopy beginning 48hrs after transfection.  Although the transfection 
efficiency was low (approximately 5-10%), we were still able to monitor GFP 
positive cells.  At days 4-6 post-transfection, cells were fixed and stained for 
beta-catenin (to better delineate cell boundaries) and nuclear DNA.  Similar to 
our adenoviral studies, we were able to capture engulfing intermediates (Figure 
22, panel a) and LIP-expressing cells that have engulfed anywhere from one to 
three neighboring cells (Figure 22, panels b-e).  In addition, we observed LIP- 
expressing cells that had broken down into vesicles (Figure 22, panel f).  Next, I 
imaged the engulfed cells using confocal microscopy in order to confirm that the 
LIP-expressing host cell had engulfed its neighboring target cell.  Figure 23 
depicts a series of images (z-stack) taken of a LIP-expressing cell that has a 
target cell within (also see movie 5).  These studies corroborate the fact that it is  
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Figure 22.  LIP-mediated cell engulfment is not dependent on adenoviral 
infection. MDA-MB-468 cells transfected with LIP and GFP expression vectors 
were stained with beta-catenin and Hoechst. Cells were imaged 4-6 days post-
transfection.  
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Figure 23.  LIP engulfment of neighboring cells via confocal microscopy. 
LIP-expressing cells stained with beta-catenin and Hoechst DNA stain were 
imaged using confocal microscopy. Images represent a series of Z-stacks.  
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the overexpression of LIP that leads to this cell engulfment phenomena and not a 
side effect of using an adenoviral system to overexpress LIP.   
LIP may play a physiological role during involution of the mammary gland. 
Despite having few clues for the mechanism underlying LIP’s ability to 
stimulate cell engulfment, we are nonetheless interested in considering possible 
physiological roles for this activity.  C/EBPbeta is a well-established regulator of  
mammary gland development during puberty, pregnancy and involution (Grimm 
and Rosen, 2003).  Involution of the mammary gland post-lactation is a 
physiological event that involves extensive cell death of the secretory epithelium 
(Monks et al., 2008).  Studies have shown that neighboring mammary epithelial 
cells (MECs) can clear dying MECs in a process termed efferocytosis (Monks et 
al., 2008). In addition to apoptotic death, lysosomal pathways of cell death or 
autophagy have been implicated to occur during involution (Zarzynska and Motyl, 
2008). Combining our observations that overexpression of LIP induces 
autophagy and leads to cell death with our observations that LIP overexpression 
leads to the engulfment of neighboring cells, we considered whether LIP may 
play a role in involution.  
Mouse mammary glands were removed at various time points including 
pregnancy, early lactation, full lactation, early involution and late involution. 
Immunoblot analysis was carried out using a C/EBPbeta antibody that 
recognizes all three C/EBPbeta isoforms.  As shown in Figure 24, we see a 
dramatic increase in LIP expression in the involuting mouse mammary glands at 
day 1 post-weaning in all three samples (lanes 5-7) isolated from separate mice.  
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Figure 24. LIP expression in mouse mammary glands. Samples were 
analyzed by 10% SDS-PAGE.  Immunoblot analysis was performed with an anti-
C/EBPbeta antibody.  Equal amounts of total protein were loaded in each lane as 
determined by Ponceau S staining.  Lane 1, 14.5d pregnancy; Lane 2, early 
lactation; Lanes 3 and 4, full lactation; Lanes 5-7, early involution (day 1 post-
wean); Lane 8, late involution (day 5 post-wean).  
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Interestingly, we do not detect LIP at late involution (day 5 post-weaning).  LIP is 
not present in the samples from late pregnancy or early lactation, but is 
detectable during full lactation.  Secretory cells are continually replenished during 
full lactation so there is likely to be some cell death during this period.  Hence, 
LIP may play a role in the removal of these dying secretory epithelial cells.  In 
any case, this preliminary data shows that LIP is elevated during early involution 
and suggests LIP may play a physiological role during mammary gland 
involution.  
 
Discussion 
In this chapter, I present data demonstrating exogenous expression of LIP 
in the human breast cancer epithelial cell line, MDA-MB-468, leads to the 
engulfment of neighboring epithelial cells.  Cell cycle profiling studies show LIP-
expressing cells have a dramatic increase in cells with more than 2n DNA 
content.  In these studies, I was able to confirm that the increase in DNA content 
is due to the engulfment of neighboring cells by using fluorescent CellTracker 
dyes to monitor this cannibalistic process.  Using a quantitative method to 
monitor cell engulfment, I was able to demonstrate on average approximately 
30% of LIP-expressing cells have engulfed a target cell.  Engulfment was 
significantly diminished upon treating with a ROCK inhibitor.  LIP-mediated 
engulfment does not appear to depend on PtdSer exposure.  When we 
performed ultrastructure analysis of LIP-expressing cells by TEM, we observe 
various engulfing intermediates as well as target cells that have been internalized 
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by LIP-expressing host cells.  Cell engulfment was observed whether or not 
adenovirus was employed to overexpress LIP. Remarkably, I was able to show 
an increase in LIP protein levels in the early stages of involution of mouse 
mammary glands. 
 When we compare our findings to those published documenting entosis 
there are some similarities and major differences.  Unlike the entosis process, 
which is described as a cell death mechanism that occurs due to loss of 
attachment to ECM, our studies were performed with matrix-attached cells.  In 
our studies, we observe LIP cells engulfing the target cells and not an invasion 
process as described in entosis.  Importantly, Overholtzer et al. examined a 
panel of human cell lines including the MDA-MB-468 human breast cancer cell 
line for possible entosis.  Interestingly, they report that 0% of these cells 
underwent the entosis process (Overholtzer et al., 2007).  However, similar to 
entosis, LIP expression leads to a nonapoptotic cell death process, live cells are 
engulfed, and this LIP mediated cannibalistic process requires ROCK activity.  
 Although our studies examined the response to exogenous LIP 
overexpression, the C/EBPbeta isoform, LIP, is elevated in a variety of processes 
such as endoplasmic reticulum (ER) stress and oncogenic signalling.  As 
discussed in Chapter 2, increased LIP levels have been reported during the late 
phase of ER stress and this increase in LIP protein level is due to both increased 
synthesis as well as increased stability of the protein (Li et al., 2008).  Also, ER 
stress induced by the proteasome inhibitor MG132 was shown to transiently 
increase C/EBPbeta mRNA levels and notably increased LIP protein levels 
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(Nakajima et al., 2011).  Whether elevated LIP levels during ER stress could 
result in cell engulfment has yet to be determined. 
 Interestingly, there are also reports that couple oncogenic signaling 
pathways such as Epidermal Growth Factor Receptor (EGFR), Human Epidermal 
growth factor Receptor 2  (HER2/ErbB2), and Insulin-like growth factor I 
Receptor (IGF-IR) to increases in LIP protein levels.  Baldwin et al. connect 
EGFR signaling in mammary epithelial cells to an increase in the LIP levels.  
They show that C/EBPbeta mRNA levels are unaffected by EGF stimulation and 
suggest that the increase in LIP expression is controlled posttranscriptionally and 
is partly due to the interaction of the translational regulatory factor CUG triplet 
repeat, RNA binding protein 1 (CUGBP1) with C/EBPbeta mRNA (Baldwin et al., 
2004).  In later studies by Arnal-Estapé et al., they report that hyperactivation of 
ErbB2 in patient-derived metastatic breast cancer samples leads to an increase 
in LIP.  Similarly, ErbB2 signaling was shown to activate CUGBP1, a 
downstream effector of ErbB2/PI3K pathway.  CUGBP1 appears to favor the 
production of LIP and inhibition of PI3K activity prevents LIP translation 
irrespectively of ErbB2 status (Arnal-Estapé et al., 2010).  More recently, IGF-IR 
signaling has also been shown to increase LIP expression in an EGFR 
independent manner in mammary epithelial cells (Li et al., 2011). Li et al. 
conclude that Akt activity is an important regulator of IGF-IR induced LIP 
expression and that this elevation in LIP plays a significant role in regulating 
cellular survival via suppression of anoikis (Li et al., 2011).  Cell-in-cell structures 
have long been noted in tumor samples, and thus it is possible that elevated LIP 
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levels consequent to oncogenic signaling could contribute to their formation by 
activating cell engulfment. 
 In regards to the clearance of live cells, studies in Drosophila have 
recently identified a new tumor-suppression mechanism that eliminates 
oncogenic imaginal epithelial cells (Ohsawa et al., 2011).  Mutant epithelial cells 
that have lost their apicobasal polarity are actually engulfed and eliminated by 
surrounding normal epithelial cells.  Engulfment is dependent on the activation of 
nonapoptotic JNK signaling in the normal imaginal cells in response to the 
emergence of neoplastic mutant cells (Ohsawa et al., 2011).  Given that many 
components of the Drosophila antitumor cell engulfment pathway are conserved 
from flies to human, Ohsawa et al speculate that this is an evolutionarily 
conserved intrinsic tumor-suppression mechanism existing in normal epithelium 
(Ohsawa et al., 2011).  Given that LIP can mediate live cell engulfment, it is 
interesting that C/EBPbeta is a downstream target of JNK signaling (Qiao et al., 
2003). 
 Now that the potential for LIP-mediated engulfment of live cells is known, 
this may enable the possible recognition of this event during times when LIP 
levels are elevated, such as mammary gland involution (shown here) as well as 
ER stress or oncogenic signaling.  Like entosis, it remains uncertain whether LIP-
mediated engulfment serves a prosurvival role (such as a mechanism to escape 
immune surveillance) or a growth/tumor suppressor role (such as intrinsic 
epithelial surveillance and/or via inducing cell death).  Specific inhibitors of the 
LIP-induced engulfment process will be necessary to address these questions.  
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Future studies aimed at characterizing the mechanism by which LIP induces 
engulfment will facilitate the development of inhibitors and thus a fuller 
understanding of its biological significance. 
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CHAPTER IV 
C/EBPbeta3 (LIP) and transcriptional regulation 
Introduction 
As described in earlier chapters, exogenous expression of LIP in breast 
cancer cells leads to engulfment of neighboring cells, which is accompanied by 
autophagy, and ultimately leads to cell death.  The ability of a transcription factor 
to stimulate cell engulfment has not, to our knowledge, previously been reported.  
In order to gain insight into the mechanism by which LIP expression leads to cell 
engulfment, autophagy, and the massive cell death that follows, we sought to 
identify some of the specific genes targeted by this transcription factor.  
 Previous studies have shown a role for C/EBPbeta in regulating 
transcription of a multitude of genes ranging from cyclooxygenase-2 (COX-2) 
(Wu et al., 2005), gluconeogenic phosphoenolpyruvate carboxykinase (PEPCK) 
(Jurado et al., 2002), receptor activator of nuclear factor kappa B ligand (RANKL) 
(Ng et al., 2010), and those encoding cytokines (IL-6, IL-1beta, TNF-alpha) to list 
a few (Yang et al., 2000; Russell et al., 2010; Bristol et al., 2009).   We decided 
that a comprehensive and unbiased approach would be the best way to proceed 
and so we performed Affymetrix genomic profiling on control (NV or GFP) or LIP-
expressing cells.  We performed genomic profiling in both MDA-MB-231 and 
MDA-MB-468 breast cancer cells.   
Despite the major phenotypic changes that result from LIP 
overexpression, there were surprisingly few changes in gene transcription using 
Affymetrix human genome U133 Plus 2.0 microarrays.  The major difference was 
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an elevation of HSPA1A gene transcription, which we further characterized using 
qPCR.  However, only a small increase in heat shock protein 70 (HSP70) cellular 
protein was detected. HSP70 has been shown to have different roles depending 
on its localization (Tytell, 2005).  Intracellularly, HSPs function as molecular 
chaperones aiding in folding and transport of an assortment of polypeptides and 
proteins under normal physiological conditions and following stress stimuli (da 
Silva and Borges, 2011). HSPs localized extracellularly or plasma membrane-
bound HSPs are known to provoke potent anti-cancer immune responses 
mediated either by the adaptive or innate immune system (van Noort et al., 
2012).  In addition, tumor cells can actively release HSP70s in lipid vesicles such 
as exosomes (van Noort et al., 2012).  
In this chapter, I demonstrate that LIP expression leads to a substantial 
but transient increase in HSPA1A mRNA.  This not only leads to a small increase 
in cellular HSP70 protein, but also an increase in HSP70-containing exosomes 
isolated from LIP-expressing cells.  We address whether these exosomes are 
involved in cell engulfment via our quantitative cell engulfment assay using flow 
cytometry. 
 
Materials and Methods 
 
Cell Culture and adenoviral constructs 
The human breast cancer cell lines MDA-MB-231 and MDA-MB-468 were 
obtained from the ATCC (Manassas, VA) and maintained as described in the 
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previous chapters.  The adenoviral constructs used in these experiments were 
the same as discussed in the previous chapters.  Cells were grown to 
subconfluency (60–70%) on 100mm dishes. Cells were either uninfected or 
adenovirally infected with Ad-GFP or Ad-LIP at a MOI: 5–10 for all experiments.  
Genomic profiling 
Total RNA was isolated 48hrs post-infection using the RNeasy Mini kit and 
RNase-Free DNase kit (Qiagen, Maryland, USA). RNA was submitted to the 
Vanderbilt Microarray Shared Resource for quality assurance. After confirming 
RNA quality, biotinylated complementary RNA was prepared, fragmented, and 
hybridized to Affymetrix GeneChip U133 PLUS 2.0 arrays.  Three independent 
replicates were performed for the MDA-MB-231 cell line.  Similar experiments 
were performed using the MDA-MB-468 cell line. 
Real-time PCR 
 RNA was extracted as described above.  cDNA was synthesized with the 
high capacity cDNA reverse transcription kit according to manufacturer’s 
instructions (Applied Biosystems, Foster City, CA, USA).  Next, Taqman real-time 
PCR was performed to determine the relative levels of targets.  GAPDH was 
used as an internal control in these experiments.  The HSPA1A probe used was 
Hs00359163_s1 (Applied Biosystems, Foster City, CA). Reactions were 
performed in a total volume of 20µL using a real-time PCR instrument 
(StepOnePlus, Applied Biosystems, Foster City, CA, USA).  
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Whole cell lysates and immunoblot analysis. 
Whole cell extracts were prepared as described in chapter 2.  Relative 
protein concentrations were determined using the Protein Assay Reagent 
(BioRad Laboratories, Hercules, CA, USA) as per manufacturer’s instructions. 
After separation by electrophoresis the proteins were transferred to an 
Immobilon®-P filter and processed as previously described.  
Exosome isolation 
Exosomes were isolated from control MDA-MB-231 cells or MDA-MB-231 
cells infected with Ad-GFP or Ad-LIP (Figure 25A).  Normal growth media was 
removed 16hrs post-infection and replaced with serum-free Iscove’s media.  At 
48hrs post-infection, media was collected from each cell population.  We used 
two different methods to isolate exosomes.  The first approach for exosome 
purification was through differential ultracentrifugation.  After collecting media, 
the initial step is designed to eliminate large dead cells and large cell debris by 
centrifugations at a lower speed.  Samples were kept on ice the entire duration of 
experiments and centrifugations were done at 4° C.  The first spin was performed 
at 800 x g for 10 minutes.  Supernatants were collected and transferred to new 
tubes. A second spin at 12,000 x g was performed for 30 minutes.  The pellet for 
each population was collected in PBS (with addition of protease and 
phosphatase inhibitors).  This fraction collected represents the microvesicles.  
Meanwhile, the supernatants were carefully removed and ultracentrifugation at 
100,000 x g for 2hrs was performed.  Following this spin, supernatant was  
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Figure 25. Schematic of experimental design.  
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removed and the pellet was resuspended in PBS (with addition of inhibitors) and 
this represents the exosomes fraction.  The second approach was using the 
ExoQuick-TCTM Exosome Precipitation Solution (Cat. # EXOTC50A-1, Systems 
Biosciences, Mountain View, CA).  Exosomes were isolated as per 
manufacturer’s instructions. 
Quantitative cell engulfment assay using flow cytometry 
In these assays, MDA-MB-468 cells were stained with CellTracker dye as 
per manufacturer’s instructions (Figure 25B).  Following the staining procedure, 
exosome pellets collected from control or (Ad-GFP or Ad-LIP) infected MDA-MB-
231 cells were added to the labeled MDA-MB-468 cells.  After 24hrs of 
conditioning with the exosomes, these MDA-MB-468 cells were mixed in a ratio 
of 3:1 with Ad-LIP or Ad-GFP MDA-468 cells as described in chapter 3.  At 24hrs 
post-mixing, cells were trypsinized and collected in phenol-red free Iscove’s 
media.  Cells were collected for flow cytometry analysis using a 3-laser 
FACSCanto II instrument, (Becton-Dickinson, San Jose, CA) equipped with 
standard 5-2-2 filter configuration.  FACSDiVa Software was used for data 
acquisition and analysis.   
 
Results 
 
Genomic profiling of LIP-expressing MDA-MB-231 cells 
 To characterize LIP regulation of gene expression in MDA-MB-231 cells, 
RNA was isolated from control (uninfected or Ad-GFP) and Ad-LIP MDA-MB-231 
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cells at 48hrs post-infection.  Isolated RNA was hybridized to Affymetrix human 
genome U133 Plus 2.0 microarrays in what is now the Vanderbilt Genome  
Sciences Resource Core.  A small number of genes, approximately 3% of the 
total represented on the U133 Plus 2.0 microarrays, showed minor alterations in 
expression in the LIP-expressing MDA-MB-231 cells 48hrs post-infection.  In 
each set of experiments, we detect between 90-103 genes that were upregulated 
1.5-fold or more in comparison to the control samples.  The number of genes 
downregulated 1.5-fold or more was between from 80-110 genes.  While we 
repeated these experiments three times, the only consistent result we obtained 
was increases in the HSPs as shown in Table 1.  We were surprised when we 
did not detect significant changes in genes that are downregulated since LIP is a 
transcription repressor.   
     Affymetrix number Gene symbol Description Fold 
increase 
200799_at HSPA1A Heat shock 
70kD protein 1A 
7 
200800_s_at HSPA1A Heat shock 
20kD protein 1A 
5.4 
213418_at HSPA6 Heat shock 
70kD protein 6 
(HSP70B') 
6 
 
117_at HSPA6 Heat shock 
70kD protein 6 
(HSP70B') 
3 
202581_at HSPA1B Heat shock 
70kD protein 1B 
3.2 
 
 
Table 1. LIP regulation of genes in MDA-MB-231 cells. Upregulated genes 
and their respective fold increase are depicted.  
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Genomic profiling of LIP-expressing MDA-MB-468 cells 
During these studies, I tested a number of breast cancer cell lines as 
presented in Figures 6, 7, and 8 in chapter 2.  We noticed that exogenous 
expression of LIP leads to cell death in all breast cancer cell lines tested. 
However, we do notice a difference in the time it takes for cells to die and the 
extent of cell death varies in the different breast cancer cell lines.  After testing 
the MDA-MB-468 cell line, it was very apparent that LIP overexpression leads to 
cell death in a larger percent of cells in the population at a given time.  Due to the 
fact that we saw small changes in the LIP-expressing MDA-MB-231 cells, that 
may have a small number of cells dying at any one time, we wanted to extend 
our studies and characterize LIP regulation of gene expression in MDA-MB-468 
cells.  RNA was isolated from control (uninfected or Ad-GFP) and Ad-LIP MDA-
MB-468 cells at 48hrs post-infection.  Isolated RNA was hybridized to Affymetrix 
human genome U133 Plus 2.0 microarrays in what is now the Vanderbilt 
Genome Sciences Resource Core.  To our surprise, even though LIP 
overexpression leads to the presence of autophagy markers (chapter 2) and 
engulfment of neighboring cells (chapter 3) that together result in massive cell 
death, we did not detect any major changes at the transcription level.  LIP 
expression in the MDA-MB-468 cell line leads to 222 genes that were 
upregulated more than 2-fold.  Table 2 shows the top 10-upregulated genes and 
their respective fold changes.  As mentioned LIP is thought to function as a 
transcriptional repressor, so it was even more surprising that we detect only 15 
genes downregulated greater than 2–fold.  This data is presented in table 2.    
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Table 2. LIP regulation of genes in MDA-MB-468 cells. * denotes genes that 
contain C/EBPbeta site in promoter. 
 
Affymetrix 
number 
Gene symbol Description Fold change 
1555436_a_at AFF4 AF4/FMR2 family, 
member 4 
3 
235645_at ESCO1 Establishment of 
cohesion 1 homolog 
1 
2.67 
220407_s_at *TGFB2 Transforming growth 
factor, beta 2 
3.8 
 
205017_s_at MBNL2 Muscleblind-like 2 3.6 
 
201730_s_at TPR Translocated 
promoter region {to 
activated MET 
oncogene} 
3.3 
222283_at ZF Zinc finger protein 
480 
2.35 
221220_s_at SCY1 SCY1-like 2 
 
2.15 
213286_at ZFR Zinc finger RNA 
binding protein 
2 
15700001_at CASP8 Casp8 and FADD-
like apoptosis 
regulator 
1.7 
 
218960_at *TMPRSS4 transmembrane 
protease, serine 4 
-3.44 
227238_at *MUC15 mucin 15, cell 
surface associated 
-3 
214829_at AASS aminoadipate-
semialdehyde 
synthase 
-2.75 
235089_at *FBXL20 F-box and leucine-
rich repeat protein 20 
-2.16 
237493_at *IL22RA2 interleukin 22 
receptor, alpha 2 
-2 
202501_at MAPRE2 (microtubule-
associated protein, 
RP/EB family, 
member 2 
-1.95 
220907_at *GPR110 G protein-coupled 
receptor 110 
-1.8 
222257_s_at *ACE2 angiotensin I 
converting enzyme 
(peptidyl-dipeptidase 
A) 2 
-1.5 
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HSPA1A mRNA increase is transient 
 As mentioned above, heat shock protein genes exhibit the largest 
changes in gene expression in response to LIP expression, specifically in MDA-
MB-231 cells.  In order to confirm this genomic profiling data, I performed Real-
Time PCR (qPCR).  RNA was isolated from control (uninfected, Ad-GFP) and 
Ad-LIP MDA-MB-231 at various time (24-96hrs) points post-infection.  We are 
able to confirm a transient increase in HSPA1A mRNA beginning at 48hrs post-
infection in the LIP-expressing MDA-MB-231 cell line.  In comparison to the 
microarray results where we detect on average a 7-fold increase, we detect up to 
a 50-fold increase in HSPA1A relative to control using qPCR.  As shown in 
Figure 26, there are still elevated levels of HSPA1A mRNA at 72hrs post-
infection.  Yet, 96hrs post-infection HSPA1A mRNA levels are similar to those 
seen in control Ad-GFP.  
 Although we did not observe an increase in HSPA1A gene expression by 
microarray analysis in the MDA-MB-468 cells, we nonetheless performed qPCR 
with RNA from these cells over a similar time course.  Interestingly, a similar 
transient increase in HSPA1A mRNA was observed in the LIP-expressing MDA-
MB-468 cells (Figure 27).  However, we detect only a 5-fold increase in HSPA1A 
transcript and this was observed 24hrs post-infection.  This result explains why 
the increase in HSPA1A transcript was missed in the microarray analysis, 
because the RNA was analyzed at 48hrs post-infection.  Nonetheless, our data 
suggest that increased HSPA1A transcription is a common response to LIP  
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Figure 26. LIP induces HSPA1A expression in MDA-MB-231 cells. RNA was 
isolated from control uninfected as well as Ad-LIP and Ad-GFP MDA-MB-231 
cells at different time points post-infection. cDNA was synthesized as described 
in Materials and Methods section. Results are presented as fold induction of 
HSPA1A compared to uninfected MDA-MB-231 cells.  This assay was repeated 
three times and t-test analysis was performed. *p-value: <0.05 
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Figure 27. LIP induces HSPA1A expression in MDA-MB-468 cells. RNA was 
isolated from control uninfected as well as Ad-LIP and Ad-GFP MDA-MB-468 
cells at different time points post-infection. cDNA was synthesized as described 
in Materials and Methods section. Results are presented as fold induction of 
HSPA1A compared to uninfected MDA-MB-468 cells. This assay was repeated 
three times and t-test analysis was performed. *p-value: <0.05 
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expression, although the specific time course and magnitude may vary by cell 
line.   
HSP70 cellular protein levels do not correlate with HSPA1A mRNA increase 
 After observing such a dramatic increase in HSPA1A mRNA in MDA-MB-
231 cells, we wanted to analyze cognate protein expression.  Following 
adenoviral infection of MDA-MB-231 cells, whole cell lysates were prepared at 
days 2, 4, and 6 post-infection.  Immunoblot analysis was carried out using an 
anti-HSP70 antibody.  Figure 26A shows a small increase in cellular HSP70 
protein at days 2 and 4 post-infection.  However, this increase in protein does not 
correlate with the 50-fold increase of HSPA1A mRNA presented in Figure 26.  In 
addition, I performed densitometric analysis of HSP70 protein levels (at days 2-5) 
relative to the control TFIID protein levels.  As shown in Figure 28B, there is little 
difference between the cell population expressing LIP and control (NV and Ad-
GFP) MDA-MB-231 cells.  
LIP expression leads to increases in exosome secretion 
In addition to its intracellular location, HSP70 is also known to be secreted 
from cells via a non-canonical pathway and the secreted HSP70 is a common 
component of exosomes (Tytell, 2005).  Exosomes are 30- to 100-nm lipid 
bilayer vesicles that function to promote intercellular communication.  Exosomes 
are derived from the fusion of multivesicular bodies with the plasma membrane 
and extracellular release of the intraluminal vesicles (Johnstone et al., 1987). 
Recent studies have focused on the biogenesis and composition of exosomes as 
well as regulation of exosome release (Schorey and Bhatnagar, 2008).  
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Figure 28. HSP70 protein levels in MDA-MB-231 cells. Whole cell lysates 
were prepared from Ad-LIP MDA-MB-231 cells, control Ad-GFP MDA-MB-231 
cells, and control uninfected (NV) MDA-MB-231 cells at different time points 
(days 2–5) post-infection and analyzed by 10% SDS-PAGE. Immunoblot analysis 
with anti-HSP70 antibody is shown. B, Densitometric analysis of HSP70 in MDA-
MB-231 cells using the ODYSSEY infrared imaging system. Data shown 
represents the mean ± SD. An anti-TFIID antibody was used as a loading control. 
Solid black bars represent the uninfected NV MDA-MB-231 cells; gray bars 
represent the Ad-GFP MDA-MB-231 cells, and the shaded bars represent the 
Ad-LIP MDA-MB-231 cells. 
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Various techniques including immunoblot analysis, immuno-EM, FACS, 
and mass spectrometry have been utilized to analyze the lipid and protein 
contents of exosomes.  Exosome composition varies depending on the cell type 
of origin.  Nevertheless, exosomes contain a number of common protein 
components for instance, Rabs, which promote exosome docking and the 
membrane fusion events; annexins, including annexin I, II, V and VI, which may 
regulate membrane cytoskeleton dynamics and membrane fusion events; several 
adhesion molecules (e.g. CD9, CD18, CD146, CD166) have also been identified 
in exosomal preparations (Schorey and Bhatnagar, 2008).  Another characteristic 
feature of exosomes is the tetraspanins, which include CD9, CD63, CD81, and 
CD151 (Schorey and Bhatnagar, 2008; Simpson et al., 2008).  
We detect a high level of HSPA1A mRNA, yet a small increase in cellular 
HSP70 protein levels.  It is known that HSP70 can also function extracellularly 
and tumor cells secrete HSP70 in exosomes.  We wanted to isolate exosomes 
from the MDA-MB-231 cell line since we see the most dramatic change in 
HSPA1A mRNA in this cell line.  In this set of experiments, we analyzed both 
HSP70 and CD151 protein levels in control (uninfected, Ad-GFP) and Ad-LIP 
infected MDA-MB-231 cells.  I used both the ultracentrifugation and/or kit method 
to isolate the exosomes.  After collecting the conditioned media and performing 
ultracentrifugation or the kit method to isolate exosomes, samples were analyzed 
by western blot.  Blots were probed with an anti-HSP antibody as well as anti-
CD151 antibody.  We detect an increase in HSP70 in the microvesicle (MV) 
fraction and the exosome fraction, of LIP-expressing MDA-MB-231 cells when we  
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Figure 29. LIP expression leads to increased exosome secretion. 
Microvesicles and exosomes were isolated from control NV MDA-MB-231 cells, 
Ad-GFP, or Ad-LIP MDA-MB-231 cells.  Samples were analyzed by western blot 
using anti-HSP70 and anti-CD151 antibodies. 
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perform the ultracentrifugation method (Figure 29).  When the exosome kit 
method was utilized, we detect an increase in HSP70 protein levels in exosomes 
of LIP-expressing MDA-MB-231 cells.  When using the kit method this procedure 
is devoid of collecting for microvesicles and the solution only isolates exosomes.  
In addition to increases in HSP70 protein levels, we also detect an increase in 
CD151 protein levels in exosomes isolated from LIP-expressing MDA-MB-231 
cells.  This suggests that we have more exosomes being secreted from LIP-
expressing MDA-MB-231 cells, which could explain why there is more HSP70 in 
the exosome sample from LIP-expressing MDA-MB-231 cells. 
LIP-derived exosomes are involved in cell engulfment 
Throughout these studies, we were puzzled by the length of time it took to 
detect both signs of autophagy and engulfment.  As shown in Figure 6, there are 
high levels of LIP at 48hrs post-infection, yet we see an increase in 2n DNA 
content at 72hrs post-infection as shown in Figure 17.  In our cell engulfment 
experiments described in chapter 3, we show LIP-expression leads to 
approximately 30% engulfment of neighboring cells at 48hrs post-mixing.  We 
were unable to detect significant levels of engulfment at 24hrs.  This suggests 
that it takes a few days of chronic LIP expression for cell engulfment to occur.  
 As shown in Figure 29, it appears that LIP-expressing cells secrete more 
exosomes.  It is known that exosomes function to promote intercellular 
communication.  To determine if exosomes were involved in “sending messages” 
to neighboring cells to prepare them for cell engulfment, we used the MDA-MB-
231 cell line.  We chose to isolate the MDA-MB-231 exosomes since we had 
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observed high levels of HSPA1A mRNA at 48hrs post-infection in this cell line.  In 
addition, we find HSP70 and CD151 protein levels increased in the exosomes 
isolated from LIP-expressing MDA-MB-231 cells.  16hrs post-infection, we 
replenished the different (NV, Ad-GFP, and Ad-LIP) cell populations with serum-
free growth media.  After an additional 24hrs, media was collected and following 
a series of centrifugation steps (Figure 25), isolated exosomes were added to 
CellTracker stained MDA-MB-468 cells.  This conditioning period lasted 24hrs. 
Next, we used Ad-LIP and Ad-GFP infected MDA-MB-468 cells and mixed these 
cell populations with the exosome-treated fluorescent-labeled MDA-MB-468 cells 
in a 1:3 ratio as described previously for the quantitative cell engulfment assays. 
24hrs post-mixing, the cell populations were analyzed by FACS to determine the 
extent of cell engulfment of neighboring cells.  Conditioning of uninfected 
fluorescent-labeled MDA-MB-468 cells with exosomes isolated from LIP-
expressing MDA-MB-231 cells leads to a dramatic increase in cell engulfment at 
24hrs post-mixing.  We detect approximately 33% of LIP-expressing cells 
engulfing their neighboring cells in comparison to the control (no exosomes) 
treatment where we only detect 11% cell engulfment 24hrs post-mix (Figure 30). 
Interestingly, conditioning of uninfected fluorescent-labeled MDA-MB-468 cells 
with exosomes isolated from LIP-expressing MDA-MB-231 cells marks these 
cells for engulfment.  
 We are able to show that GFP-expressing MDA-MB-468 cells can also 
engulf neighboring cells considerably once they have been conditioned with  
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Figure 30. LIP-derived exosomes are involved in cell engulfment. 
Quantification of the percent of GFP positive cells that have engulfed uninfected 
CellTracker labeled cells at 24hrs post-mixing. Solid bars represent LIP-
expressing MDA-MB-468 cells. Gray bars represent Ad-GFP control MDA-MB-
468 cells. The following samples were either with no exosome treatment or with 
treated with exosomes isolated from the respective MDA-MB-231 cell line. 
Sample 1: no exosome treatment; Sample 2: LIP exosomes; Sample 3: Ad-GFP 
exosomes; Sample 4: uninfected (NV) exosomes.  
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exosomes isolated from LIP-expressing MDA-MB-231 cells.  Without exosome 
treatment of target cells, cell engulfment with Ad-GFP cells was a meager 5% as 
shown in Figure 20 and Figure 30.  However, conditioning of the target cells with 
LIP-derived exosomes leads to 25% cell engulfment.  This suggests that 
exosomes derived from the LIP-expressing population may be involved in 
delivering messages to neighboring cells that marks them for cell engulfment. 
Conditioning with exosomes isolated from control Ad-GFP and NV MDA-MB-231 
cells leads to a small increase of cell engulfment in comparison to target cells not 
exposed to exosomes. Nevertheless, a substantial increase in cell engulfment is 
observed in the cell populations that were conditioned with LIP-derived 
exosomes.  We conclude from these studies that LIP may mediate cell 
engulfment by inducing the release of messages, in the form of exosomes, that in 
someway alter target cells to become “engulfable”. 
 
Discussion 
As discussed in previous chapters exogenous expression of the 
transcription factor LIP in breast cancer cells leads to engulfment of neighboring 
cells, which is accompanied by autophagy, and ultimately leads to cell death. In 
this chapter we set out to determine the genes that are regulated by LIP. To our 
surprise, the genomic profiling studies revealed very few changes in both the 
MDA-MB-231 and MDA-MB-468 cell lines at the 48hrs post-infection time point. 
LIP expression in the MDA-MB-231 cell line does lead to a striking increase in 
HSPA1A mRNA transcript. These results were further confirmed using qPCR. 
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Yet, for a 50-fold upregulation in transcript, we confirm only a small increase in 
cellular HSP70 protein levels. When we profiled the MDA-MB-468 cell line, we 
had expected to uncover genes that may be involved in the dramatic phenotype 
we illustrate in chapters 2 and 3.  Yet, we were astonished to find that again very 
little changes were found at 48hrs post-infection.  It is important to note that 
HSPs were not identified as an upregulated candidate in the microarrays 
performed with the MDA-MB-468 cells. However, as shown in Figure 2 that is 
due to the fact that we see upregulation of HSPA1A mRNA transcript 24hrs post-
infection.  We cannot conclude that LIP stimulation of autophagy and cell 
engulfment is not mediated through any transcriptional regulation, since we 
observe many changes are in fact transient. We know there is great 
heterogeneity in these cell populations and the autophagy and cell engulfment 
process is not synchronized, therefore it would be difficult to pinpoint the most 
appropriate window of time that could be used to study changes in gene 
expression due to LIP.  
In our attempt to track down changes in HSP70 protein expression, we 
were able to document an increase in HSP70-containing exosomes in the culture 
medium of LIP-expressing MDA-MD-231 cells.  Remarkably, the exosomes from 
LIP-expressing cells may contain message(s) that significantly increase the 
engulfability of target cells exposed to these exosomes.  The fact that up to 25% 
of MDA-MB-468 cells only expressing GFP can engulf their neighbors, when 
conditioned by exosomes from LIP-expressing cells, suggest that engulfing other 
cells does not actually require elevated LIP expression.  Rather it is the 
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conditioning of the target cells, conferring “engulfability” on them, that occurs 
upon LIP overexpression in neighboring cells.  In other words, LIP does not 
convert cells into predators, so much as it alters cells into becoming prey.  
Exosomes appear to be one method for communicating with cells and converting 
them into “prey”.  Our findings do not exclude, other, perhaps soluble factors 
from being involved as well.  Exosomes are complex entities typically comprised 
of over 300 different proteins, as well as RNA, including microRNA and even 
DNA.  The nature of the specific exosomal message(s) and how they convert an 
otherwise resilient target cell into an engulfable one, could be a complex task to 
identify.  One interpretation of our data is that the lag between LIP 
overexpression and significant cell engulfment is due to the time required to 
convert a potential target cell into a engulfable one once exposed to exosomes 
secreted from LIP-expressing cells.   Further research, in particular uncovering 
the nature of the messages exchanged exosomally, should help to determine if 
this interpretation is correct. 
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CHAPTER V 
Summary and Discussion 
 
The transcription factor C/EBPbeta is a critical player during mammary 
gland development.  It plays a role in proliferation, differentiation, and cell death. 
As reported with other transcription factors (e.g., SNAIL, Twist) that are important 
during development, C/EBPbeta has been shown to affect tumor formation and 
progression in various organs including the mammary glands. Interestingly, the 
gene encoding C/EBPbeta (CEBPB) is not mutated in breast tumors.  Little 
mutations have been identified in CEBPB, and those that do occur are not 
believed to promote epithelial cancers.  CEBPB may, however, be amplified in a 
small subset of breast neoplasia.  Alterations common to lobular carcinoma in 
situ of the breast include a gain at 20q13.13, which contains CEBPB 
(Mastracci et al., 2006).  
When C/EBPbeta mRNA levels were queried with Oncomine 3.0 array, 
data analysis performed revealed that expression of C/EBPbeta mRNA is not 
altered in breast cancer cell lines or breast tumor tissue in comparison to normal 
breast tissue (Rhodes et al., 2005).  Further gene expression studies have also 
shown that C/EBPbeta mRNA is unchanged and not altered in breast cancer 
upon stimuli such as oncogenic ErbB receptor activation.  Still, differences in 
C/EBPbeta mRNA expression are observed among a few breast cancer 
subtypes.  For instance, Oncomine analysis showed that a modest, but 
significant increase in C/EBPbeta mRNA is observed in estrogen-receptor-
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negative breast cancers versus those tumors that are positive for the estrogen 
receptor. Also, an elevation in C/EBPbeta mRNA is associated with metastatic 
breast cancer, a high tumor grade, and an overall poorer prognosis (Milde-
Langosch et al., 2003).  While the data suggest that transcriptional control or 
regulation of mRNA stability may be a mechanism for CEBPbeta expression in 
more aggressive breast cancers, C/EBPbeta frequently goes under the radar in 
many genomic profiling studies.  This is due to the fact that C/EBPbeta 
expression is significantly regulated at the translational level and multiple 
C/EBPbeta isoforms are produced.  Translation of this intronless gene leads to 
the production of three protein isoforms, each with a distinct function in the 
mammary gland.  
C/EBPbeta1 has been shown to play a role not only in differentiation, but 
our work demonstrates an important role for C/EBPbeta1 in oncogene-induced 
senescence (Atwood and Sealy, 2010).  Our lab demonstrated a role for 
C/EBPbeta2 in proliferation, transformation, and epithelial-to-mesenchymal 
transition in culture (Bundy and Sealy, 2003).  When we characterized 
C/EBPbeta in normal versus neoplastic mammary epithelial cells, we show an 
increase in C/EBPbeta2 protein levels in patient breast tumor samples.  Contrary 
to others, we did not observe an increase in C/EBPbeta3 (LIP) in patient breast 
tumor samples; in fact LIP was undetectable (Eaton et al., 2001).  In recent 
years, there has been progress in delineating the roles and differences between 
C/EBPbeta1 and C/EBPbeta2; yet the role of LIP is very unclear.  In this work I 
set out to investigate the role of LIP in breast cancer.  This thesis aims to 
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characterize the induction of autophagy as well as describe the ability to engulf 
neighboring cells which ultimately leads to cell death upon LIP expression in 
breast cancer cell lines.   
Autophagy and Cancer  
Autophagy is an intracellular process through which cytosolic components, 
ranging from lipids, proteins, carbohydrates and nucleotides to whole organelles 
and invading pathogens, are targeted for lysosomal degradation.  Currently, our 
understanding of whether autophagy is an ally or enemy in breast cancer 
development, progression and treatment remains ambiguous.  Interestingly, 
cancer was the first human pathology connected to autophagy through the 
discovery that Beclin1, a core component of the autophagosome nucleation 
complex, was monoallelically deleted in 40–75% of sporadic human breast, 
ovarian and prostate cancers.  Reduction in autophagic activity in early stages of 
the oncogenic process favors malignant transformation, as the accumulation of 
certain molecules can activate signaling mechanisms that promote necrosis and 
inflammation.  In addition, poor quality control as a result of diminished 
autophagy can result in accumulation of defective organelles (e.g. mitochondria), 
with the subsequent release of harmful molecules (cytochrome c and reactive 
oxygen species) that contribute to further altering genome maintenance.  In later 
stages of tumor progression, activation of autophagy is observed in many 
oncogenic processes, in part to compensate for the poor nutritional supply 
associated with growing tumors and to defend cancer cells against damage 
induced by anti-oncogenic therapies.  In addition, enhanced mitochondrial 
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degradation in this stage may contribute to the up-regulation of glycolysis to 
maintain the energetic balance (Warburg effect) characteristic of malignant cells. 
Effectors and modulators of autophagy have become attractive targets in the 
treatment of cancer.  
Like many cellular processes, a fine balance in the autophagic process is 
essential.  While autophagy may play dual roles, it seems that the status of the 
cell, whether normal or transformed, is of great importance.  Additionally, it is 
critical to not only focus on the role of autophagy in epithelial cells, but the 
surrounding microenvironment is most likely also playing a role during tumor 
progression.  The role of autophagy in stromal cells is a very poorly understood 
area that needs to be studied in greater detail.  Complete inhibition of autophagy 
as that proposed by many investigators may lead to an initial decrease in tumor 
size or inhibition of cell survival in metastatic cells, but it may also lead to more 
aggressive tumors or the development of different death-causing diseases.  
Using genetically engineered mouse models for cancer where autophagy is 
inhibited, Eileen White’s group recently demonstrated that inhibition of autophagy 
does not alter the survival rate of mice bearing lung tumors. Lung tumors of 
genetically engineered mice accumulate defective mitochondria, and while there 
is an induction of growth arrest, there is no effect on survival.  They conclude that 
these mice have massive increases in the inflammatory response and this leads 
to a pneumonia-like death.   
In general, whether the focus is on autophagy or other mechanisms, I 
believe it is essential to find ways to specifically target tumor cells. Clearly, this is 
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very challenging as tumor cells were basically normal cells until their regulatory 
systems were hijacked.  Otherwise, general inhibition of any process, like the use 
of chemotherapy, is ultimately going to be an issue of weighing out the benefits 
over the detrimental effects.  
C/EBPbeta3 (LIP) and Cancer 
In a similar way, identifying the role of LIP in breast cancer development 
has been somewhat complicated.  While Zahnow’s group reported high levels of 
LIP protein expression in breast tumor samples, our own studies do not 
corroborate these results.  In addition, Zahnow et al. report transgenic mice that 
overexpress LIP in the mammary gland develop focal and diffuse alveolar 
hyperplasia as well as small percent (9%) form non-invasive carcinomas 
(Zahnow et al., 2001).  Unfortunately, because the LIP transgene was not 
epitope-tagged in these mice it is not possible to ascertain transgene expression 
distinguished from any endogenous LIP expression.  Moreover, the level of LIP 
expression (transgene or endogenous) in the mammary tumors was not actually 
examined.  On the other hand, work published by Meir et al. demonstrates a 
decrease in tumor size of LIP overexpressing mice.  They conclude LIP 
augmented ER stress-triggered cell death whereas overexpression of 
C/EBPbeta2 (LAP) attenuated cell death (Meir et al., 2010).  Hence, the puzzle of 
LIP’s role in tumorigenesis remains to be solved. 
C/EBPbeta3 (LIP) and autophagy: explaining the paradox? 
The work in chapter 2 of this document describes the role of LIP in 
stimulating the self-cannibalization process of autophagy and inducing cell death 
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in breast cancer cell lines.  I provide evidence for this by monitoring autophagy 
using various well-accepted methods (e.g. ultrastrucure analysis and 
autophagosome formation), performing cell proliferation assays, as well as 
colony formation assays.  Figure 6 and figure 7 demonstrate that high levels of 
LIP attenuate proliferation and lead to cell death in the MDA-MB-468 and MDA-
MB-231 cell lines.  I also show that LIP overexpression does not lead to a cell 
cycle block or apoptotic (type I) or necrotic (type III) cell death.  In addition, I 
provide evidence of autophagy in LIP-expressing cells by ultrastructure analysis 
of MDA-MB-231 cells.  In these studies, I detect an increase in various different 
autophagic vesicles and lamellar structures found in later stages of autophagy. 
Using different biochemical methods we were able to confirm that LIP-expressing 
cells have an increase in acidic vesicles.  Along those lines, we detect an 
increase in LC3-II protein levels in LIP-expressing cells indicative of 
autophagosome formation.  Finally, I show that LIP expression leads to DOR 
shuttling from the nucleus to the cytoplasm.  
This study is important because our finding that LIP expression is involved 
in the autophagic process may help resolve the paradox over whether LIP is pro- 
or anti-tumorigenic.  This may be due to the fact that autophagy has dual roles in 
cancer as described above.  We propose that at early stages of tumor 
development, LIP expression leads to attenuation of cell proliferation, induction of 
autophagy and cell death of damaged cells. Yet at later stages, expression of LIP 
may stimulate autophagy and lead to cell survival, playing a pro-tumorigenic role.  
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Figure 31. LIP may have dual roles in tumor development and progression. 
At early stages of tumor development, LIP may have anti-tumorigenic roles. LIP 
expression attenuates proliferation, stimulates autophagy that may lead to the 
demise of damaged cells. Later stages of tumor progression, LIP stimulation of 
autophagy may lead to cell survival providing a pro-tumorigenic role.  
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The intensely investigated process of autophagy continues to evolve.  
Interestingly, proposed increases in autophagy are based on the fact that levels 
of autophagy-related proteins are higher during certain drug treatments or 
stimulation by various factors.  Yet, up-regulation of autophagy markers does not 
necessarily mean increased autophagic flux.  In fact, evidence suggests that if 
autophagy is functioning properly, accumulation of autophagic compartments 
rarely occurs.  Accordingly, it is possible that the observed increase in 
autophagic markers is actually a reflection of a compromise in the clearance of 
autophagic compartments, rather than in their formation. Accumulation of 
autophagolysosomes can contribute to cell toxicity and be detrimental for the 
affected cells.  Remarkably, this toxic effect of the ‘congestion’ of the autophagic 
pathway is currently being explored for therapeutic purposes.  
C/EBPbeta3 (LIP) and cell engulfment 
While exogenous expression of LIP leads to the presence of autophagic 
markers it also leads to massive cell death.  Low levels of LIP may stimulate 
autophagy and promote cell survival, but our data provides evidence that high 
levels of LIP leads to cell death.  Yet, many of the original claims of “cell death by 
autophagy” have currently been revised and reformulated as “cell death with 
autophagy”.  These revisions led us to further query the literature for different 
types of cell death that do not involve apoptosis or necrosis. Through this 
literature mining, we came across entosis, a nonapoptotic cell death mechanism 
by cell-in-cell invasion.  During this process, the internalized cells detected in 
suspended MCF10A and MCF7 cultures closely resemble commonly observed 
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cytological features referred to as cell-in-cell or cell cannibalism in clinical cancer 
specimens.  These features are most frequently detected in metastatic tumor 
cells that grow in a partial state of suspension in fluid exudates, as those 
observed in the pleural space surrounding the lungs.  During entosis, cells that 
are grown in suspension invade neighboring cells and this leads to the formation 
of cell-in-cell structures.  This in vitro model mimics distinguishing features of the 
cell-in-cell phenomenon observed in human tumor cells in fluid exudates.  In their 
studies, Overholtzer et al. suggest that entosis may have tumor suppressive 
roles, as the fate of many target cells is cell death.  Additionally, they assayed 
MCF7 cells for anchorage-independent growth in soft agar.  Inhibiting entosis 
leads to a 10-fold increase in colony formation implying that entosis could oppose 
proliferation to inhibit the number and size of soft agar colonies.  Entosis, 
however, is not the only process described in the literature that leads to cell-in-
cell structures.  Many have described various homotypic and heterotypic cell 
interactions since the 1800’s.  Yet, the exact role of cell-in-cell structures is 
poorly understood.  Interestingly, they are frequently associated with metastatic 
disease.  To our knowledge, there are no reports of a transcription factor that 
may play a role in live cell engulfment. 
In chapter 3 of this work, the data presented illustrates a role for LIP in 
mediating cell engulfment.  Overexpression of LIP in breast cancer cell lines 
leads to cell death.  It also leads to the appearance of very vacuolated cells and 
multinucleated cells.  When we analyzed the DNA content of LIP-expressing 
cells, we were able to detect an increase in cells that had more than 2n DNA 
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content in this population.  After this initial clue that LIP may be involved in cell 
engulfment, we used a number of tools to monitor this process. Taking 
advantage of fluorescent-labeled dyes and microscopy, we were able track the 
green LIP-expressing cells engulfing neighboring fluorescent-labeled cells as 
illustrated in Figure 18.  We monitored this process by live cell imaging and found 
that engulfed cells can also be released.  However, it is likely that the fate of the 
majority of engulfed cells is cell death.  In addition, we were able to detect the 
disintegration of both host and target cells in our live cell imaging experiments. 
Ultrastructure analysis was performed and we found various engulfing 
intermediates and the presence of a target cell within the host cell’s vacuole. I 
was able to develop a quantitative method to monitor cell engulfment and on 
average we detect 30% of LIP-expressing cells engulf target cells.  Engulfment 
was significantly diminished upon treating with a ROCK inhibitor.  Engulfment 
does not appear to require “eat me” signals (PtdSer exposure). Notably, cell 
engulfment was observed whether or not adenovirus was employed to 
overexpress LIP.  
Engulfment can be pro- or anti- tumorigenic 
The role of cell-in-cell structures, which is defined as a cell enclosing 
another cell within its cytoplasm, is becoming an important morphologic feature 
to distinguish benign from malignant lesions.  There are various processes that 
have been described that lead to cell-in-cell structures.  Ongoing research is 
focused on the nature and the significance of processes such as entosis and cell 
cannibalism in cancer.  Entosis was shown to have tumor suppressive roles and 
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the majority of the live cells that invade into neighboring cells end up dying 
through lysosomal cell death.  While LIP-expressing cells have similar 
characteristics to those described during the entosis process, LIP expression 
resembles more of a cell cannibalism process.  In our case, LIP-expressing cells 
actively engulf the neighboring cells. As previously mentioned, cell-in-cell 
phenomenon have been observed in human tumor cells in fluid exudates. When 
Gomis et al. examined pleural effusion samples isolated from patients with 
metastatic breast cancer, this study found an elevation in LIP protein levels.  
While the exact role of cell cannibalism is unknown one can speculate that 
it may be a feature of malignant cells to control tumor growth.  It may be one of 
the last attempts to remove neighboring cells before they reach their metastatic 
site.  In 1984, Brouwer et al. reported that in cell lines of human small cell 
carcinoma of the lung (SCCL), cells were observed which completely interiorized 
other cells leading to death of the target cells and many times to complete self-
destruction of the cultures.  They refer to this phenomenon as “cell cannibalism” 
and found it to be conserved in fresh tumor biopsies from SCCL patients.  Cell 
cannibalism was absent in serum-free cultured cells but could be re-induced by 
serum exposure.  Therefore they proposed that serum factors are responsible for 
the induction of cannibalism in cells.  In different ultrastructural studies, 
lysosomal structures are noted to be scarce in cannibalistic host cells in 
comparison to the target cells.  Therefore, it has been postulated that the target 
cells apparently die due to the lack of nutrition.  If engulfment or cell cannibalism 
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leads to cell death of the target cell and many times both the target and host cell 
die, then cell cannibalism may play a role in tumor suppression (Figure 32). 
In recent Drosophila studies, Ohsawa et al. have identified a new tumor-
suppression mechanism that eliminates oncogenic imaginal epithelial cells 
(Ohsawa et al., 2011).  Mutant epithelial cells that have lost their apicobasal 
polarity are actually engulfed and eliminated by surrounding normal epithelial 
cells.  Engulfment is dependent on the activation of nonapoptotic JNK signaling 
in the normal imaginal cells in response to the emergence of neoplastic mutant 
cells (Ohsawa et al., 2011).  Given that many components of the Drosophila 
antitumor cell engulfment pathway are conserved from flies to human, Ohsawa et 
al speculate that this is an evolutionarily conserved intrinsic tumor-suppression 
mechanism that may also exist in normal epithelium (Ohsawa et al., 2011).  
Inducing cell cannibalism that leads to this form of “neighborhood watch” and 
leads to cell death could be a valuable way of inducing alternative cell death 
programs in tumors that have defective apoptotic machinery. 
There is an abundant amount of work published since the mid 1950’s that 
shows that tumor cells can engulf not only their siblings, but also a variety of cell 
types.  Heterotypic interactions have been reported between tumor host cells and 
neutrophils, lymphocytes, natural killer (NK) cells, as well as erythrocytes to list a 
few (Overholtzer and Brugge, 2008).  NK cell internalization has been shown to 
precede target tumor cell death and NK cell self-destruction, suggesting that this 
cell-in-cell pathway is a mechanism to kill tumor cells (Xia et al., 2008).  On the 
other hand, there is data to suggest that tumor cells can engulf and kill  
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Figure 32. LIP may have dual roles in tumor progression. LIP stimulates 
engulfment of neighboring cells, which leads to the removal and death of these 
sibling tumor cells. Hence, LIP engulfment may have anti-tumorigenic roles. 
However, LIP may stimulate engulfment of immune cells, which leads to escape 
of immune surveillance providing a pro-tumorigenic role.  
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lymphocytes, neutrophils, and T cells that are involved in tumor immune 
response.  Therefore, metastatic tumor cells may use cannibalism as mechanism 
to escape tumor immune surveillance.  If tumor cells not only escape immune 
surveillance, but also cannibalize sibling cells to survive in adverse conditions 
such as those they encounter during metastasis this behavior favors a pro-
tumorigenic role for cell cannibalism (Figure 32).  Understanding the role of cell 
cannibalism in cancer is thus imperative as it can be utilized as an innovative 
pharmacological target in the clinical management of metastatic disease. 
Using the quantitative cell engulfment assays described in this work would 
be a good method to address whether LIP-expressing cancer cells can engulf all 
cells including “normal” epithelial cells.  As described by Ohsawa et al., mutant 
epithelial cells that have lost their apicobasal polarity become targeted for 
engulfment. These cells are eliminated by surrounding normal epithelial. Future 
studies could focus on cell polarity and its role in LIP-mediated cell engulfment.   
In addition, it is important to test whether overexpression of LIP in other breast 
cancer cell lines leads to this same phenomenon.  Finally, it is of great interest to 
determine whether LIP-expressing cancer cells engulf immune cells, such as NK 
cells or macrophages.  
C/EBPbeta3 (LIP) and transcriptional regulation 
In order to gain insight into the mechanism by which LIP expression leads 
to cell engulfment, autophagy, and the massive cell death that follows, we sought 
to identify some of the specific genes targeted by this transcription factor.  We 
were surprised when we detected such few changes in gene expression in both 
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cell lines tested.  While large fold changes were absent at the 48hr post-infection 
time point, it is important to note that it could be the sum of all the small fold 
changes that are essential for the phenotype observed upon LIP expression.  
Nevertheless, we do detect a significant increase in HSPA1A mRNA levels in the 
MDA-MB-231 cells, which I confirmed with qPCR.  While we detect a small 
increase in cellular HSP70 protein, I was able to show a substantial increase in 
HSP70 in exosomes isolated from LIP-expressing MDA-MB-231 cells.   
Although LIP is thought to function as a transcription repressor, the most 
significant change we observed is an increase in HSPA1A transcripts. Hence, 
LIP may play other roles besides transcription repression in cells.  We are unable 
to conclude at this time whether the transcriptional upregulation is through direct 
regulation via DNA binding or whether LIP indirectly regulates transcription 
through combinatorial control and its interactions with numerous factors in the 
nucleus.  LIP may repress or through protein-protein interactions sequester 
factors including repressors that may be involved in regulating HSPA1A 
transcription.  
C/EBPbeta3 (LIP) and exosome secretion 
It is known that exosomes play a role in intercellular communications and 
we tested whether these exosomes are involved in cell engulfment.  Conditioning 
of cells with LIP-derived exosomes lead to an increase in cell engulfment at 
24hrs post-infection.  This data suggest that LIP-derived exosomes are “carrying 
messages” to target cells to mark them for engulfment.  While we were always 
puzzled by the length of time it took to observe changes in autophagy markers,  
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Figure 33. LIP-mediated cell engulfment.  High levels of LIP lead to 
increases in exosome secretion. These exosomes deliver messages which 
condition neighboring cells and “marks” them as target cells for engulfment.   
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engulfment, and cell death upon LIP expression, one possibility for the lag 
between LIP overexpression and significant cell engulfment may be due to the 
time required to mark cells as potential targets.  Once exposed to exosomes 
secreted from LIP-expressing cells, this marks the cell to be engulfed and 
destroyed (Figure 33).    
What changes or marks these cells for engulfment is an area that needs to 
be further explored.  It is known that exosomes contain between 300-500 
proteins. mRNAs and even miRNAs are also components of exosomes.  It would 
be interesting to compare exosomes isolated from control uninfected, Ad-GFP,  
and Ad-LIP MDA-MB-231 cells.  Proteomic analysis, genomic profiling, as well as 
miRNA profiling would be very useful tools to gain information on the contents of 
LIP-derived exosomes. It is also known that different cells phagocytose 
exosomes based on specific molecules that may coat the outer surface of the 
exosomal membrane.  While we do not detect changes in PtdSer exposure in 
LIP-expressing cells, it would be valuable to determine whether LIP-derived 
exosomes present different types of “eat me” signals including PtdSer exposure 
that can be recognized by the target cells.  
 Additionally, while there are many types of “eat me” signals described in 
the literature, there are new findings that also describe “don’t eat me” signals.  
Recent work shows that CD47 functions as a binding partner for 
thrombospondin-1 and as a ligand for the transmembrane signal regulatory 
protein (SIRP)-alpha.  CD47 appears to function as a molecular switch from 
“don’t eat me signal” to “eat me” signals depending on its conformational change 
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and interaction partners.  Expression of the glycoprotein CD31 has also been 
shown to be function as a “don’t eat me” signal.  Thus, characterizing the cell 
surface expression of these proteins in the control uninfected, Ad-GFP, and Ad-
LIP MDA-MB-468 cells is of great interest.  
LIP expression may lead to many cell fates 
 Our data provides strong evidence that exogenous expression of LIP leads 
to cell death. However, our time-lapse microscopy and conditioning with LIP-
derived exosomes allows us to speculate on the many cell fates that can occur 
due to LIP overexpression (Figure 34).  As the time-lapse movies show, engulfed 
cells can be released.  Whether these cells that escape stay alive and are 
somewhat more aggressive, sustaining harsh conditions while in the lysosome of 
the host cell and staying alive, is a possibility that cannot be ruled out and an 
area for further investigations.  As shown in movie 4, cells that have been 
engulfed appear to disintegrate along with the host cells. We also detect LIP-
expressing cells that have engulfed two or more cells. This hyperphagic behavior 
may also lead to cell death due to oxidative imbalances in the cell.  In fact, Tinari 
et al., propose that large amounts of toxic species derived from the over-
ingestion of oxidized components and organelles from cannibalized cells, could 
provoke cell death (Tinari et al., 2008). LIP overexpression may also lead to 
overconsumption of itself with the continuous stimulation of autophagy.  In these 
studies, we did not perform autophagic flux experiments. It may very well be that 
LIP overexpression blocks the completion of autophagy and hence this leads to 
increases in toxic substances leading to the demise of the cell.  Finally, we show  
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Figure 34.  The many cell fates of LIP-expressing cells. LIP expression can 
result in cell being released and possibly staying alive or disintegrating. LIP 
overexpression may lead to cell death due to hyperphagia or overconsumption of 
other cells or itself. 
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preliminary data that LIP-derived exosomes mark neighboring cells as prey. 
Neighboring cells that are not overexpressing LIP can then engulf these target 
cells.  Uncovering the mechanism(s) by which LIP overexpression marks cells as 
prey for cell engulfment and ultimately leads to cell death is an area that merits 
future investigation. This may lead to a greater understanding of not only how 
cells communicate in the tumor microenvironment, but help find ways to deliver 
messages of self-destruction to tumor cells or even stromal cells that may be 
feeding the tumor cells.  
A possible physiological role for LIP-mediated cell engulfment  
The mammary gland undergoes cycles of growth, differentiation, milk 
secretion, regression, and remodeling. C/EBPbeta is critical for normal mammary 
gland development.  Each C/EBPbeta isoform may play a role at different stages 
of mammary gland development.  Our studies provide strong evidence that 
exogenous expression of LIP leads to cell engulfment of neighboring cells.  In an 
attempt to uncover a physiological role for LIP-mediated cell engulfment, we 
analyzed LIP protein levels during involution. Involution begins with the cessation 
of milk secretion. During this process, the mammary gland resorbs the elaborate 
milk-producing lobuloalveoli generated during pregnancy and returns to its 
rudimentary, ductal state.  Phagocytes and neighboring living epithelial cells 
engulf dying cells to prevent inflammation and autoimmune response against 
intracellular antigens.  Interestingly, when we analyzed LIP protein levels at 
different stages of the mammary gland (pregnancy, lactation, to involution), we 
were able to show that LIP protein levels increase in mouse mammary glands 
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during the involution process. 
It is well known that key mechanisms involved in normal mammary gland 
development are hijacked, bypassed or corrupted during the development and 
progression of breast cancer. From our data, we can speculate that LIP levels 
are increased in the involuting gland in order to engulf and remove dying cells. 
Remarkably, exosomes are present and function at the different stages of 
mammary gland development (Hendrix and Hume, 2011).  For instance, breast 
milk has been shown to contain exosomes with the capacity to influence immune 
responses in infants.  Also, exosome-secreted milk fat globule EGF factor 8 
(MFG-E8) is involved in the recognition and clearance of apoptotic mammary 
epithelial cells during mammary involution (Hendrix and Hume, 2011).  Since we 
observe an increase in LIP levels during involution and we show LIP-derived 
exosomes may mark cells for engulfment, it would be fitting to examine the 
expression levels of MFG-E8 or factors similar to it that are involved in the 
recognition and targeting of neighboring tumor cells in the MDA-MB-468 cells. 
Remodeling of the mammary gland during involution is associated with an 
influx of immune cells, MMP-dependent ECM reorganization and loss of 
basement membrane functions with subsequent release of growth factors and 
bioactive fibronectin fragments.  For this reason, it is proposed that the involution 
process supports metastasis.  Additionally, some suggest that exosomes 
released during involution communicate to regional lymph nodes or distant 
organs, inducing a favorable niche for cancer cells.  However, it would be 
beneficial to find a way to hijack the early steps of this normal physiological 
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process during cancer and cause the engulfment of neighboring tumor cells, 
which ultimately leads to cell death.  
In conclusion, this work demonstrates a role for C/EBPbeta3 (LIP) in 
stimulating autophagy and cell engulfment in breast cancer cells. 
Exogenous expression of LIP leads to an increase in exosome secretion, 
which appear to communicate with target cells and mark them for 
engulfment. High levels of LIP ultimately lead to cell death in breast cancer 
cell lines. A normal physiological role for these processes induced by LIP 
may occur during involution of the mammary gland postlactation.   
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